Gefitinib (ZD1839)

Catalog No.S1025

Gefitinib (ZD1839) Chemical Structure

Molecular Weight(MW): 446.90

Gefitinib (ZD-1839) is an EGFR inhibitor for Tyr1173, Tyr992, Tyr1173 and Tyr992 in the NR6wtEGFR and NR6W cells with IC50 of 37 nM, 37nM, 26 nM and 57 nM, respectively.

Size Price Stock Quantity  
In DMSO USD 191 In stock
USD 147 In stock
USD 270 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Cited by 93 Publications

14 Customer Reviews

  • c, HCC4006 lung cancer cells that have acquired a high-mesenchymal state concomitant with becoming resistant to gefitinib (red curve) exhibit increased sensitivity to GPX4 inhibition.

    Nature, 2017, 547(7664):453-457. Gefitinib (ZD1839) purchased from Selleck.

    Perturbation of EGFR by its ligand EGF and gefitinib (ZD-1839 Iressat; inhibits EGFR) produces opposite responses in the predicted EGFR target genes SOCS2 and NR2E1.

    Mol Syst Biol 2011 7, 486. Gefitinib (ZD1839) purchased from Selleck.

  • Effects of shRNA-mediated RECK depletion on EGFR signaling in MEFs. (a) Immunoblotting (IB) of the indicated proteins in wild-type MEFs transduced with the indicated shRNAs and cultured for 48 h in the presence of 0.1% dimethyl sulfoxide (DMSO; vehicle) or 1 mM gefitinib (S1025, Selleck Chemicals,Houston, TX, USA). (b) Immunoprecipitation from whole lysates of cells from panel a with an anti-phosphorylated tyrosine (pTyr) antibody. Precipitates from 500 mg protein in whole cell lysates (upper) or 20 mg protein in whole cell lysates (lower) were analyzed by IB with anti-EGFR antibody.

    Oncogene 2010 30, 737-750. Gefitinib (ZD1839) purchased from Selleck.

    (B–C) LNCaP (B) and LNCaP-AI (C) cells were transiently transfected with sPLA2-IIa(-800)-Luc (0.5 μg). The cells were then treated with Erlotinib (20 μM), Gefitinib (20 μM), Lapatinib (20 μM), CI-1033 (8 μM), LY294002 (20 lM) and Bortezomib (20 μM) without or with EGF (100 ng/ml) for 24 h. Luciferase assay was performed according to a standard protocol with Renilla luciferase as an internal control. Data are presented as the mean (±SD) of duplicate values of a representative experiment that was independently repeated for five times.

    Carcinogenesis 2010 31, 1948–1955 . Gefitinib (ZD1839) purchased from Selleck.

  • LNCaP-AI cells were starved in 1% stripped medium for 24 h. The cells were then treated with Erlotinib (20 μM), Gefitinib (20 μM), Lapatinib (20 μM), CI-1033 (8 μM), LY294002 (20 μM) and Bortezomib (20 μM) for 24 h. Cell culture medium was collected from each sample and subjected to ELISA for sPLA2-IIa. The condition medium samples were diluted 10 times for ELISA. Average of duplicate samples was converted to nanogram per milliliter against standard curve. The data represent one of five repeated experiments.

     

     

    Carcinogenesis 2010 31, 1948–1955. Gefitinib (ZD1839) purchased from Selleck.

    Suppression of EGFR signaling by Gefitinib is dose dependent and non- toxic at millimolar concentrations.Results from plaque reduction tests of Hep2 cells infected with VACV(12.5pfu/well) treated with a serial dilution of Gefitinib (1000-0.01 m) and analyzed for (A)proliferation as indicator of cytotoxicity,(B) IC50 of plaque size inhibition, (C)dose dependent inhibition of EGFR-ERK1/2signaling and VACV proteins by Western blot analysis (pEGFR detection was obtained from a different experiment with identicals ettings) and (D)dose dependent inhibition of orthopoxvirus genome replication by real-time PCR.Untreated VACV infectedcells and uninfected cells are shown as controls in the right panel.

    Antiviral Res 2010 89, 64-70. Gefitinib (ZD1839) purchased from Selleck.

  • A circular zone of EGFR activated but uninfected cells facilitate virus induced plaque development , efficiently blocked by Gefitinib. (A)Immun of luorescent staining of aplaque reduction tests with Hep2 cells 24,48,72 and 96 h after VACV infection (6.25pfu/chamber). VACV infected cells(green) were visualized by human IgG directed to orthopoxviruses (VIG) detected with a secondary FITC labelled antibody. Uninfected cells with activated EGFR signaling(red) are detected with a secondary Cy3labelled antibody. Positive cells for both , VACV and phosphorylated EGFR are shown in yellow(merge). Cellular nuclei are counterstained with DAPI. (B)Immunofluorescent staining of a plaque reduction test as described for (A) and treated with three different Gefitinib concentrations (1000 nM, 1 nM, and 0.01 nM) . The test was analyzed 96h afterVACV infection.Uninfected cells are shown as controls. Magnification100×.(For interpretation of the references to color in this figure legend , the reader is referred to the web version of the article.)

     

     

    Antiviral Res 2010 89, 64-70. Gefitinib (ZD1839) purchased from Selleck.

    Susceptibility of lung cancer cells to cytolytic activity of NK-92 cells after treatment with EGFR inhibitors. Three lung cancer cells were untreated (open circle) or treated with 10 μM erlotinib or gefitinib (black filled square or black filled triangle) for 24 hours. The lung cancer cells were cocultured with NK-92 cells at indicated effector to target ratio (E:T ratio). To determine the specificity of NKG2D-mediated cytolysis of lung cancer cells, NK-92 cells were preincubated with blocking mAb against NKG2D before the assay (gray filled square and triangle) and correspond-ing isotype mAb (open square and triangle).

    J Immunother 2011 34(4), 372-81. Gefitinib (ZD1839) purchased from Selleck.

  • Inhibition of 5-HT-induced 5-HT3A and 5-HT3AB receptor currents.

    Eur J Pharmacol, 2017, 821:21-28. Gefitinib (ZD1839) purchased from Selleck.

    The EGF-dependent increased association of PCM1 and AZI1 requires EGFR kinase activity. ZD1839 (Iressa)—EGFR tyrosine kinase inhibitor.

    Mol Biosyst 2011 7, 3223-33. Gefitinib (ZD1839) purchased from Selleck.

  • Reduction of GPER expression in HCC1806 cells after treatment with gefitinib. (A) Concentration dependence. HCC1806 cells were treated with 50-500 nM gefitinib for 48 h. GPER was detected by western blotting. (B) Time dependence. HCC1806 cells were treated with 200 nM gefitinib for 24-96 h. ap<0.05 vs. control; bp<0.001 vs. control. Mean values and SE of three independent experiments are shown. (C) Representative western blotting of concentration dependence. (D) Representative western blotting of time dependence

    Oncol Rep, 2017, 37(2):1212-1218. Gefitinib (ZD1839) purchased from Selleck.

    Inhibition of signaling pathway activation in lung tumor cell lines by kinase inhibitors. Lung tumor cells were cultured in 10% FBS until reaching ∼80% confluence and then the cells were starved in serum-free medium for overnight, followed by 4-hour treatment with the inhibitors. Cell lysates were then prepared and used for determination of the pathway activation signals by the CEER assay.

    Int J Proteomics 2011 215496. Gefitinib (ZD1839) purchased from Selleck.

  • Breast cancer cells were pretreated with 100ng/ml EGF for 15 min and then treated with the indicated concentrations of  Gefitinib for 24 hours.

     

     

    2010 Dr. Zhang of Tianjin Medical University. Gefitinib (ZD1839) purchased from Selleck.

    MTT assay result. 0-500nM Gefitinib treated with H1299, H358, H25 and HCC827 cell lines by 72h, Proliferation rate was tested.

     

     

    2010 Dr. Vicky Tin from University of Hong Kong. Gefitinib (ZD1839) purchased from Selleck.

Purity & Quality Control

Choose Selective EGFR Inhibitors

Biological Activity

Description Gefitinib (ZD-1839) is an EGFR inhibitor for Tyr1173, Tyr992, Tyr1173 and Tyr992 in the NR6wtEGFR and NR6W cells with IC50 of 37 nM, 37nM, 26 nM and 57 nM, respectively.
Features A potent EGFR tyrosine kinase inhibitor.
Targets
Tyr1173 (NR6W cells) [1] Tyr1173 (NR6wtEGFR cells) [1] Tyr992 (NR6wtEGFR cells) [1] Tyr992 (NR6W cells) [1]
26 nM 37 nM 37 nM 57 nM
In vitro

Gefitinib effectively inhibits all tyrosine phosphorylation sites on EGFR in both the high and low-EGFR-expressing cell lines including NR6, NR6M and NR6W cell lines. The phosphorylation sites Tyr1173 and Tyr992 are less sensitive requiring higher concentrations of Gefitinib for inhibition. Gefitinib effectively blocks the phosphorylation of PLC-γ, with IC50 of 27nM, in NR6W cells. The NR6wtEGFR and NR6M cell lines has low levels of PLC-γ phosphorylation but the level in the NR6M cell line is more resistant to inhibition by Gefitinib with IC50 of 43 nM and 369 nM, respectively. Gefitinib inhibits Akt phosphorylations, with IC50 of 220 and 263nM, in the low-EGFR- and -EGFRvIII-expressing cell lines, respectively. Gefitinib in the dose range from 0.1 to 0.5μM significantly facilitates, rather than abrogates, colony formation of NR6M cells. However, at a concentration of 2 μM Gefitinib completely blocks NR6M colony formation. Gefitinib rapidly and in a dose-dependent manner inhibits EGFR and ERK phosphorylation up to 72 hours after EGF stimulation in both the high- and low-EGFR-expressing cell lines. [1] Gefitinib is the monolayer growth of these EGF-driven untransformed MCF10A cells with an IC50 of 20 nM. [2] The combination of Gefitinib (0.2 μM and 0.5 μM) with irradiation lead to a significant growth inhibition in LoVo cells, compared with radiation alone.. [3]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
KB NVe0[ZZJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYTJR|UxRTBwMEW0JO69VQ>? MkXxNVY2OTZ2N{O=
NIH3T3 M2TQTmZ2dmO2aX;uJGF{e2G7 M4nEfFAvOiEQvF2= MnHVNkBp MmLQSG1UVw>? Mn30TY5pcWKrdHnvckBw\iCHR1[gd5RqdXWuYYTl[EBpfW2jbjDldoJDOSCjdYTvdIhwe3Cqb4L5cIF1cW:wIIfpeIghUUN3MDDv[kAxNjBzNESg{txO MXqxOlQ5ODJ6NB?=
COS7 M3fy[2Z2dmO2aX;uJGF{e2G7 MoC5PVYh|ryP NGnxephKdmirYnn0bY9vKG:oIHj1cYFvKEqDS{KgWlYyP0ZibYX0ZY51KGW6cILld5Nm\A>? NIPsco4yPzF5OEeyNi=>
A549 MX;DfZRwfG:6aXOgRZN{[Xl? NULrNJh6QTZiaB?= NXyw[VFPTE2VTx?= M2DqcWlEPTB;MUOuOVkh|ryP NHvmRnYyQDNzM{iwOy=>
K562 NW\0Z3VOS3m2b4TvfIlkKEG|c3H5 NWK3RlY6QTZiaB?= NV7LV5dSTE2VTx?= M3z3VWlEPTB;OT6zOkDPxE1? MoPWNVg{OTN6MEe=
MDA-MB-231 NGS2UlFEgXSxdH;4bYMhSXO|YYm= MVe5OkBp NGmwfmlFVVOR NUDFTY9YUUN3ME2zOk43OSEQvF2= Moq1NVg{OTN6MEe=
MOLT4 NWG3O3dWS3m2b4TvfIlkKEG|c3H5 MXS5OkBp NYXLb2JETE2VTx?= NWHmWIN3UUN3ME2xOU4xOiEQvF2= MYixPFMyOzhyNx?=
MCF7 NH7CS5BEgXSxdH;4bYMhSXO|YYm= NX\4[oY3PTBizszN NEHKWoQ4OiCq Ml\LTWM2OD1zMj6wOUDPxE1? NWKyXJliOTh5N{G4NVk>
BT474 M1XxSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYfweZdSPzJiaB?= NHrUeG9CdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFLUOFc1KGOnbHzzJI93\XKneIDy[ZN{cW6pIFXSRoIzKHerdHigSWM2OCCxZjCwMlMh|ryP NV70fmd4OTlyMki0NlQ>
HN5 MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NG\rNFE4OiCq MYjBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEiQNTDj[YxteyCxdnXy[ZhxemW|c3nu[{BGT0[UIIfpeIghTUN3MDDv[kAxNjBzIN88US=> MoXoNVkxOjh2MkS=
BA/F3 M1npN2N6fG:2b4jpZ{BCe3OjeR?= NIrodmY4OiCq NHPTOI9EgXSxdH;4bYNqfHliYXfhbY5{fCCvb4Xz[UBDSS:IMzDj[YxteyCneIDy[ZN{cW6pIFXHSnIhVDh3OGKgcZV1[W62IIfpeIghUUN3MDDv[kAxNjBzMEig{txO MV2xPVI{QTJ{OR?=
NIH3T3 NG\ETVdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGDTbVg4OiCq NYHJXI9[T3Kxd4ToJIlvcGmkaYTpc44hd2ZibX;1d4UhVkmKL{PUN{Bk\WyuczDlfJBz\XO|aX7nJIVzSjJiZ3Xu[UB4cXSqIFnDOVAhd2ZiMD61OEDPxE1? MkTwNVk3PjV|N{e=
MCF7 MX M2myXGZ2dmO2aX;uJGF{e2G7 M{\0elMxKG2rbh?= NXrZfWNGUW6qaXLpeIlwdiCxZjDCR3JRKGW6cILld5Nm\CC5aYToJGlEPTBib3[gNU4yKM7:TR?= MmjxNVk6OzJ7NkC=
A431 MmfkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4myeVExKM7:TR?= NXn3Sm5qPzJiaB?= NW\vdJVST0l3ME2wMlUyPCEQvF2= MYKxPVk3QTR4NR?=
A431 MVrLbY5ie2ViQYPzZZk> M{ixUlAvOSEQvF2= M2qz[|EhcA>? MYHJcohq[mm2aX;uJI9nKEWJRj3pcoR2[2WmIFXHSnIheGixc4Doc5J6dGG2aX;u NEiyZY0yQTl4OUS2OS=>
A431 MX3LbY5ie2ViQYPzZZk> M4TDblExOCEQvF2= NXjIZpBIOTBibXnu MlnKVJJwdG:wZ3XkJIlvcGmkaYTvdpkh[WO2aY\peJkhd2ZiRVfGMYlv\HWlZXSgSWdHWiCyaH;zdIhwenmuYYTpc44> M2f0S|E6QTZ7NE[1
Sf9 M3vITmtqdmG|ZTDBd5NigQ>? MlnSNVAhdWmw MkDvSG1UVw>? M4XvfmlvcGmkaYTpc44hd2ZiRVfGVkBmgHC{ZYPz[YQh[XO|ZYPz[YQh[XNiaX7obYJqfGmxbjDv[kBz\WOncITvdkBifXSxcHjvd5Bpd3K7bHH0bY9vKHerdHigTWM2OCCxZjCwMlA{OyEQvF2= M4HP[VIxODV4NEK1
NCI-H1975 M2LFUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWKzOI01PSEQvF2= NHv2[G44OiCq MV3JR|UxRThwMk[g{txO MmfiNlAyPTF4N{C=
NCI-H1975 MYPLbY5ie2ViQYPzZZk> NInqZZgyOCEQvF2= NHTWdZBKdmirYnn0bY9vKG:oIFXHSnIh[XW2b4Doc5NxcG:{eXzheIlwdg>? NEjLVpozODF3MU[3NC=>
NCI-H1975 MXzGeY5kfGmxbjDBd5NigQ>? MVOxNEDPxE1? MYDJcohq[mm2aX;uJI9nKEWUQlKyJIF2fG:yaH;zdIhwenmuYYTpc44> MlPoNlAyPTF4N{C=
NCI-H1975 MUHGeY5kfGmxbjDBd5NigQ>? M1\OZVUh|ryP NITBToI1QCCq M3TuSWlv\HWldHnvckBw\iCjcH;weI9{cXNiYYPz[ZN{\WRiYYOgZYN1cX[jdHnvckBw\iClYYPwZZNmNTN? NGnSO|UzODF3MU[3NC=>
A375 MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{P5cVQ5KGh? MorSTWM2OD1{MD61OUDPxE1? MXyyNFMxPDV|Nx?=
SMMC7721 M1zhN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVL3WFFSPDhiaB?= MmfMTWM2OD1|Mz6xNkDPxE1? MUiyNFMxPDV|Nx?=
DU145 NGHWXmlEgXSxdH;4bYMhSXO|YYm= NFXNWlU2KGR? MWjEUXNQ MWPJR|UxRTR{LkG3JO69VQ>? M2fMWlIxPDZ4NUW1
MIAPaCa2 NWn6VJlNS3m2b4TvfIlkKEG|c3H5 NXjNWpBlPSCm M3XnXmROW09? NIHXdphKSzVyPUWwMlYzKM7:TR?= MYOyNFQ3PjV3NR?=
PANC1 MYPDfZRwfG:6aXOgRZN{[Xl? M3WzWFUh\A>? NHHNSVlFVVOR Mn;DTWM2OD12MD60NkDPxE1? M2L3SFIxPDZ4NUW1
PC9 M2DQZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVPBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IFXHSnIu\GWoaXPp[Y51KGi3bXHuJHBEQSClZXzsd{B4cXSqIFXDOVAhd2ZiMD6wNVch|ryP NV;HNmQ5OjF{MEi4NFI>
PC9 M1rISWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1fOTmFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4Sg[5Jwf3SqLYLld4l{fGGwdDDoeY1idiCSQ{mgZ4VtdHNiZYjwdoV{e2mwZzDFS2ZTKEV5NE\fRVc2OC:WN{mwUUBufXSjboSge4l1cCCHQ{WwJI9nKDdizszN M2TsSFIyOjB6OECy
PC3 MlfPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVWxNEDPxE1? MX[3NkBp MmnRSG1UVw>? MXnJR|UxRTdwNDFOwG0> NELxWJMzOTN3M{W0Oi=>
MDA-MB-468 NGPnWoJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFTaeocyODBizszN NYr2W3NJPDhiaB?= Mn;sSG1UVw>? MXXBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eR?= NF72OGkzOTR{OU[zNi=>
Plasmodium falciparum M1jSR5FJXFNicILv[oltcW6pIH\vdkBqdmirYnn0c5J{KG:oIGDsZZNud2SrdX2g[oFt[2myYYL1cUBxem:uaX\ldoF1cW:w M2TnUFIyQDF5MES1
NCI-H1993 M3L3emdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnXKO|IhcA>? NFe4TndFVVOR NFS2cHVKSzVyPUCuNUDPxE1? MUOyNVkyPjR|Mx?=
NCI-H292 NHXqc|NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MX:3NkBp NV3UZodQTE2VTx?= MmHVTWM2OD1yLkCyJO69VQ>? MV2yNVkyPjR|Mx?=
A431 NHPNSVhMcW6jc3WgRZN{[Xl? MV2yJIg> M{O3UGROW09? NEHDfGVKdmirYnn0bY9vKG:oIFXHSnIheGixc4Doc5J6dGG2aX;uJIlvKEWJRj3zeIlufWyjdHXkJIh2dWGwIFG0N|Ehf2m2aDDJR|UxKG:oIECuNFAyKM7:TR?= MWiyNlExOTF|Mh?=
MCF7 M1\PWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFGxVHYyODEEoN88[{9uVA>? MVS0PEBp Mo\MSG1UVw>? NUTUW4RZSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDNR2Y4KGOnbHzzJI93\XKneIDy[ZN{cW6pIFXHSnIh\2WwZTD3bZRpKEmFNUCgc4YhOTJwMEWg{txO NULaZYpWOjJzMUmxN|A>
BT474 NYn2XGRYS3m2b4TvfIlkKEG|c3H5 M1PFcVExKM7:TR?= NUW3PJp2PDhiaB?= NF:zZ4FEgXSxdH;4bYNqfHliYXfhbY5{fCC|ZYL1cU1{fGG{dnXkJIh2dWGwIFLUOFc1KGOnbHzz NH\kPWgzOjF|OEOwPC=>
MCF7 Mon6R5l1d3SxeHnjJGF{e2G7 MXixNEDPxE1? Ml3KOFghcA>? MXvDfZRwfG:6aXPpeJkh[WejaX7zeEB{\XK3bT3zeIFzfmWmIHj1cYFvKE2FRkegZ4VtdHNib4\ldk1mgHC{ZYPzbY5oKEW{YlKyJINmdGy| MYGyNlE{QDNyOB?=
HCC827 M1SwZWtqdmG|ZTDBd5NigQ>? M3;MelAvOTJ3IN88US=> MXWyOEBp M{[5cmROW09? MYDJcohq[mm2aX;uJI9nKEWJRmKg[IVtKEV5NE[tRVc2OCCvdYThcpQhYTFyNkigZZV1d3Cqb4PwbI9zgWyjdHnvci=> NYHOR2pEOjJ|M{mzOFI>
HCC827 NFTPc5hMcW6jc3WgRZN{[Xl? M{DMelAvOTJ3IN88US=> Mo\BNlQhcA>? NHradW9FVVOR NGPBS25KdmirYnn0bY9vKG:oIFXHSnIh\GWuIFW3OFYuSTd3MDDteZRidnRvbXXkbYF1\WRiRYLrJJBpd3OyaH;yfYxifGmxbh?= MWCyNlM{QTN2Mh?=
HCC827 M2fTeWtqdmG|ZTDBd5NigQ>? NILYencxNjF{NTFOwG0> NHjm[ZUzPCCq NGjMd5VFVVOR NUTkcpNxUW6qaXLpeIlwdiCxZjDFS2ZTKGSnbDDFO|Q3NUF5NUCgcZV1[W62LX3l[IlifGWmIFHreEBxcG:|cHjvdplt[XSrb36= Ml36NlI{Ozl|NEK=
A431 MWPLbY5ie2ViQYPzZZk> NHnGSoQyODBizszN Mn7nN|AhdWmw MWPJcohq[mm2aX;uJI9nKEWJRmKg[IVzcX[nZDDmdo9uKGi3bXHuJGE1OzFiY3XscEBu\W2kcnHu[UBie3Onc4Pl[EBieyCrbnjpZol1cW:wIH;mJJBwdHlvR3z1MXR6eiCyaH;zdIhwenmuYYTpc44hf2m2aDDJR|UxKG:oIEGuNFgh|ryP MYqyNlY6QDd6Mh?=
H460 MVjDfZRwfG:6aXOgRZN{[Xl? M{TFcVczKGh? MWrJR|UxRTVwNUmg{txO NFrTNoczOjd{N{S0PS=>
HT-29 NH3lSYREgXSxdH;4bYMhSXO|YYm= Mly5O|IhcA>? NYDMT49vUUN3ME2zMlM3KM7:TR?= M3nMW|IzPzJ5NES5
SGC7901 NVPUTFRsS3m2b4TvfIlkKEG|c3H5 NIS0dlY4OiCq NGHtN3FKSzVyPUGwMlI3KM7:TR?= MYSyNlczPzR2OR?=
A498 MnnqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHvRZoNCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFG0PVgh[2WubIOg[ZhxemW|c3nu[{BGT0[UIHHu[EBUWkNid3n0bEBKSzVyIH;mJFgvPiEQvF2= MmfWNlI5OTh6NEi=
Calu3 NXnNd|VQS3m2b4TvfIlkKEG|c3H5 NITn[GkyOCEQvHevcWw> M4C5[|czKGh? NEfTRlRKSzVyPUGuOkDPxE1? NGW4flIzOzFzNkG2PC=>
FADU NYLubWxrS3m2b4TvfIlkKEG|c3H5 MorpNVAh|rypL33M NH:0OW44OiCq M1\jNGlEPTB;MD6wOUDPxE1? M1T4Z|I{OTF4MU[4
HCC827 MWHDfZRwfG:6aXOgRZN{[Xl? MV[xNEDPxGdxbVy= MmHTO|IhcA>? M{PRZmlEPTB;MD6wNFE2KM7:TR?= MnmxNlMyOTZzNki=
PC9 M{L0bGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mm[3NVAh|rypL33M MlXaO|IhcA>? MorCTWM2OD1yLkCwNVQh|ryP MX[yN|EyPjF4OB?=
Sf9 MX;LbY5ie2ViQYPzZZk> NVjndnRiOSCq MofsSG1UVw>? MoLVTY5pcWKrdHnvckBw\iCqdX3hckBIW1RvdHHn[4VlKEWJRmKgUFg{PFJibYX0ZY51KGW6cILld5Nm\CC5aYToJGlEPTBib3[gNE4xOTVizszN Mlj1NlM3OTF4OUG=
16HBE14o- NYPJVJRDS3m2b4TvfIlkKEG|c3H5 NIn0UpUyOCEQvF2= M1\vUFczKGh? M4[wV2ROW09? M2rTb2N6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJFE3UEKHMUTvMUBk\WyuczDoZZJjd3Krbnege4lt\CC2eYDlJGVITlJiYYPz[ZN{\WRiYYOg[5Jwf3SqIHnubIljcXSrb36ge4l1cCCLQ{WwJI9nKDF{LkexJO69VQ>? NUHFTINsOjN4Nki0OFE>
NCI-H1975 NIXlOlJEgXSxdH;4bYMhSXO|YYm= NYD4XHNFOTBizszN MWi3NkBp M2PsZWROW09? NYHuc4hUS3m2b4TvfIlkcXS7IHHnZYlve3RiZ3XmbZRqdmmkLYLld4l{fGGwdDDoeY1idiCQQ1mtTFE6PzViY3XscJMhcGG{Yn;ybY5oKEWJRmKgUFg2QFJxVEe5NG0h\G:3YnzlJI12fGGwdDDhd5Nme3OnZDDhd{Boem:5dHigbY5pcWKrdHnvckB4cXSqIFnDOVAhd2ZiNj65NVch|ryP NXXmcFlROjN4Nki0OFE>
16HBE NHzrNYVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmTzO|IhcA>? MnPWSG1UVw>? MkPlRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiBzNljCSUBk\WyuczDlfJBz\XO|aX7nJJdqdGRidInw[UBGT0[UIIfpeIghUUN3MDDv[kAyNjZyMTFOwG0> NIrSV3kzOzd7MkOxPC=>
16HBE M4m1XGZ2dmO2aX;uJGF{e2G7 M{fUSFExOCEQvF2= MoTxNVUxKG2rbh?= NXSyXJllTE2VTx?= NYnFPIhzUW6mdXP0bY9vKG:oIH7peJJq[yCxeHnk[UBxem:mdXP0bY9vKGmwIHj1cYFvKDF4SFLFJINmdGy|IHX4dJJme3Orbnege4lt\CC2eYDlJGVITlJ? MXKyN|c6OjNzOB?=
A549 NXjsUppmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{j4T|czKGh? NUL3SGo2TE2VTx?= NV7QdGo{SW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEB4cWymIIT5dIUhTUeIUj;rMXJieyCmZYDlcoRmdnRiaIXtZY4hSTV2OTDj[YxteyC5aYToJGlEPTBib3[gOE43OjZizszN NVHDNnJPOjN5OUKzNVg>
SH-SY5Y MYTDfZRwfG:6aXOgRZN{[Xl? NWHaRohmPzJiaB?= NWjTRXA2UUN3ME2xPE4zOSEQvF2= MlqzNlM5PzF7MEm=
LoVo MlW2T4lv[XOnIFHzd4F6 MV:yJEBp MWTEUXNQ NGn4PHhKdmirYnn0bY9vKG:oIFXHSnIheGixc4Doc5J6dGG2aX;uJJdqfGhiSVO1NEBw\iByLkC2NkDPxE1? M3;McVI{QTNyOUm0
PC9 MXvLbY5ie2ViQYPzZZk> Mlu4NkBp NFO1OXVFVVOR NYPiZldRUW6qaXLpeIlwdiCxZjDFS2ZTKGW6b36gNVkh\GWuZYTpc44h[WO2aY\heIlv\yCvdYThcpQheGixc4Doc5J6dGG2aX;uJIlvKGi3bXHuJHBEQSClZXzsd{B4cXSqIFnDOVAhd2ZiMD6wNFg4KM7:TR?= Mn65NlM6OzB7OUS=
HCC827 NEnkU4NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1LN[|czKGh? MkiyTWM2OD1yLkCxNkDPxE1? NGfGfJQzOzl5M{G2PC=>
A549 NVXXPGFjU2mwYYPlJGF{e2G7 NF3FTFEyKM7:TR?= NXjjXXhEOSCq MXjEUXNQ NX3me2Z[UW6qaXLpeIlwdiCxZjDFS2ZTKGG3dH;wbI9{eGixconsZZRqd25id3n0bEBKSzVyIH;mJFAvODN7OTFOwG0> NUS4UGx7OjN7OEizOVQ>
A549 MoC0SpVv[3Srb36gRZN{[Xl? NWXYS2NEOSEQvF2= M1\vXlEhcA>? MYrEUXNQ NHTUUJlE\WyudXzhdkB2eHSja3W= M4DES|I{QTh6M{W0
HCC827 MVfLbY5ie2ViQYPzZZk> NHq3TJgxNjVizszN NIq1No0zKGh? MVfEUXNQ NFvLV2FKdmirYnn0bY9vKG:oIFXHSnIheGixc4Doc5J6dGG2aX;uJIlvKGenZnn0bY5q[i2{ZYPpd5RidnRiaIXtZY4hUEOFOEK3JINmdGy| M2LUT|I{QTl|M{K4
HCC827 NXHIZ5NtTnWwY4Tpc44hSXO|YYm= MXGwMlUh|ryP MVGyJIg> NFP5OIhFVVOR NUK3O3VWUW6qaXLpeIlwdiCxZjDjMW1mfCCyaH;zdIhwenmuYYTpc44hcW5iZ3XmbZRqdmmkLYLld4l{fGGwdDDoeY1idiCKQ1O4Nlch[2WubIO= NEjYeHozOzl7M{OyPC=>
HCC827 NHy0TXVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4HSdVExKM7:TR?= NGfLNJM4OiCq Mm\PSG1UVw>? M4TOfGFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4Sg[4VncXSrbnniMZNmdnOrdHn2[UBpfW2jbjDIR2M5OjdiY3XscJMhcGG{Yn;ybY5oKEWJRmKgSVc1PiC2bzDBO|UxKGSnbHX0bY9vKHerdHigTWM2OCCxZjCwMlAxPThzIN88US=> NXH3d5FZOjRyNUO2O|Q>
A431 NITNO5lMcW6jc3WgRZN{[Xl? NXe0fo15OTByIN88US=> NXOxR45oOzBibXnu NHrE[pJKdmirYnn0bY9vKG:oIFXHSnIhcW5ic3jl[EBu\W2kcnHu[UB3\XOrY3zld{B4cXSqIFnDOVAhd2ZiMT6xJO69VQ>? NFPTTpgzPDB7NESzNi=>
BCRP-MDCK2 MV3GeY5kfGmxbjDBd5NigQ>? NVn6TndbOS56IN88US=> MWq3NkBp NWDqXXFjTE2VTx?= MY\JcoNz\WG|ZTDv[kBxdGG|bXGgcYVu[nKjbnWg[ZhxemW|c3nvckBw\iCEQ2LQJIV5eHKnc4PpcochemWyb4L0[ZIh\2WwZTDHSnA> M1fCO|I1OTh2MkGz
BCRP-MDCK2 NYTDW2JpTnWwY4Tpc44hSXO|YYm= MY[xMlgh|ryP MkX5O|IhcA>? NXHid5NWTE2VTx?= NITzeHNT\WS3Y4Tpc44hd2ZicHzhd41iKG2nbXLyZY5mKGW6cILld5Nqd25ib3[gRmNTWCCneIDy[ZN{cW6pIILldI9zfGW{IHflcoUhT0[S NFLy[ZczPDF6NEKxNy=>
MDCK MnTiR5l1d3SxeHnjJGF{e2G7 MX23NkBp NIf6cFdFVVOR MVLHTVUxRTFwNEWg{txO NIrMeWQzPDF6NEKxNy=>
MDCK2 MXzGeY5kfGmxbjDBd5NigQ>? NFKzOHkyNjhizszN NX3TXWM5PzJiaB?= M1i1NWROW09? MYjJcohq[mm2aX;uJI9nKGi3bXHuJGJEWlBiZYjwdoV{e2WmIHHzd4V{e2WmIHHzJGhw\WOqc4SgN|M{PDJiYXPjeY12dGG2aX;uJJdqfGhiSVO1NEBw\iB|LkG5JO69VQ>? MVOyOFE5PDJzMx?=
A431 MkmxR5l1d3SxeHnjJGF{e2G7 M4fDWVczKGh? M1vyS2ROW09? MmTsR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gRVQ{OSClZXzsd{BmgHC{ZYPzbY5oKEWJRmKge4l1cCCLQ{WwJI9nKDBwNUWg{txO Mm[4NlQ1OTFzMkO=
Calu3 M1nERmN6fG:2b4jpZ{BCe3OjeR?= MoXVO|IhcA>? M4HlXmROW09? NVOyXnkyS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hS2GudUOgZ4VtdHNiZYjwdoV{e2mwZzDISXIzKHerdHigTWM2OCCxZjCwMlk6KM7:TR?= NILSPIEzPDRzMUGyNy=>
KB MmH2T4lv[XOnIFHzd4F6 NYXINmF6OTBizszN M4HJSVEhcA>? M{HxWGROW09? MnnnTY5pcWKrdHnvckBw\iCHR1[td5RqdXWuYYTl[EBifXSxcHjvd5Bpd3K7bHH0bY9vKG:oIFXHSnIhf2m2aDDJR|UxKG:oIECuNFI2KM7:TR?= M4PvbFI1PDFzMUKz
BEAS2B NXziWnFoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGi2O|k2OCEQvF2= NIPGTGY4OiCq NEfpcZNFVVOR NGfkNoVKSzVyPUGzMlk1KM7:TR?= MXGyOFYxPzV7MR?=
NCI-H1975 NX7IUmo2TnWwY4Tpc44hSXO|YYm= MXGxNFAh|ryP NEG2c2IyPTBibXnu NWjrWXpYTE2VTx?= NUfrWYVvUW6mdXP0bY9vKG:oIF7PJJBzd2S3Y4Tpc44hcW5iaIXtZY4hVkOLLVixPVc2KGOnbHzzJIhiemKxcnnu[{BGT0[UIFy4OVhTN1R5OUDNJI12fGGwdB?= NF;xfGwzPDZyN{W5NS=>
Hela MonHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIDlSnYzPCCq M1LxOWROW09? NXnsPYxnUUN3ME2yMlY4KM7:TR?= NHXkfFQzPDd|MUK4NS=>
HepG2 MmqwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NV3aWHd2OjRiaB?= NHu5b2RFVVOR MY\JR|UxRTZwNEKg{txO MViyOFc{OTJ6MR?=
Sf9 MlTvT4lv[XOnIFHzd4F6 NHTwb5IyOCCvaX6= MkTHSG1UVw>? MWHJcohq[mm2aX;uJI9nKGG3dH;wbI9{eGixconsZZRqd25ib3[gdoVkd22kaX7hcpQhcGm|LYTh[4dm\CCHR1\SJEhidWmwbzDhZ4llKDZ2NT2xNVg3MSCneIDy[ZN{\WRid3n0bEBKSzVyIH;mJFAvODJizszN NW\2OmdNOjR5M{GyPFE>
SW620 MXXDfZRwfG:6aXOgRZN{[Xl? MV60PEBp NW\uTVc6TE2VTx?= NH\SW2hKSzVyPUK4MlIh|ryP MoPWNlQ6ODB3OUS=
HCC827 M3X4XmZ2dmO2aX;uJGF{e2G7 NWPyO5pKOC53IN88US=> NYfkSIxoOiCq Mm[2SG1UVw>? MmjC[I9meyCwb4SgbY5pcWKrdDDjMW1mfCCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKEGNVDDwbI9{eGixconsZZRqd25? M4jTZ|I{QTl|M{K4
HCC827 MXHGeY5kfGmxbjDBd5NigQ>? NEPZRmoxNjVizszN MlXFNkBp MUPEUXNQ NGXkeIRld2W|IH7veEBqdmirYnn0JIMuVWW2IHHzd4V{e2WmIHHzJIlvcGmkaYTpc44hd2ZicES0M|QzKHCqb4PwbI9zgWyjdHnvci=> M2n2[|I{QTl|M{K4
HCC827 NYPwXoF6S3m2b4TvfIlkKEG|c3H5 Ml\QNE42KM7:TR?= MWi3NkBp MUHEUXNQ NVfZT4R7cGG|IH7vJIN6fG:2b4jpZ4l1gQ>? NIXaXWczOzl7M{OyPC=>
NCI-H1975 MlvESpVv[3Srb36gRZN{[Xl? M{\0RlExKM7:TR?= MkHxPEBp NEfvUZJFVVOR M{LtO4Rw\XNibn;0JIlvcGmkaYTpJGVITlJiYYPz[ZN{\WRiYYOgdoVlfWO2aX;uJIlvKEWUSzDwbI9{eGixconsZZRqd25? MWCyN|EyPjF4OB?=
A431 MX7LbY5ie2ViQYPzZZk> MWexJO69VQ>? MXexJIg> M2mwVWROW09? Mk\zbIF{KG6xIHnydoV3\XK|aXLs[UBqdmirYnn0bY9vKG:oIFXHSnIh[XW2b4Doc5NxcG:{eXzheIlwdg>? NVH6WmNvOjR7MEC1PVQ>
LNCaP MlvaSpVv[3Srb36gRZN{[Xl? M{G5cVExKM7:TR?= MnfGNoghd3JiNDDo M1HncGROW09? NXnYN4Fi\G:nczDuc5QhcW6qaXLpeEBifXSxcHjvd5Bpd3K7bHH0bY9vKG:oIHntcZVvd3C3cnnmbYVlKG[uYXeteIFo\2WmIFLtfEBie3Onc4Pl[EBieyCrbnPvdpBwemG2aX;uJI9nKFt|MmDdRXRR M3TaVlE5PjZ5M{Gy
H1975 MV\LbY5ie2ViQYPzZZk> MYqxJO69VQ>? M2\DNlI1KGh? NYHDTXdOTE2VTx?= MYLkc4V{KG6xdDDpcohq[mm2IFXHSnIheGixc4Doc5J6dGG2aX;uJIlvKGi3bXHuJGgyQTd3IHPlcIx{KGijcnLvdolv\yCHR1\SJGw5PTiUL2S3PVBOKG23dHHueC=> MVuyOFYxPzV7MR?=
H1975 NHK0XIpHfW6ldHnvckBCe3OjeR?= MWWxJO69VQ>? NXvrd|VZOjRiaB?= MWnEUXNQ M3;VZoRw\XNibn;0JIlvcGmkaYSgSXJMKHCqb4PwbI9zgWyjdHnvckBqdiCqdX3hckBJOTl5NTDj[YxteyCqYYLic5JqdmdiRVfGVkBNQDV6Uj;UO|kxVQ>? MlPFNlQ3ODd3OUG=
HCC827 Mlm5T4lv[XOnIFHzd4F6 MorJNE4yOSEQvF2= NHjMV5oyKGh? M{DVb2ROW09? NVvWOFlRcGG|IH7vJIlzemW4ZYLzbYJt\SCrbnjpZol1cW:wIH;mJGVITlJiYYPz[ZN{\WRiYYOgdoVkd3[ncomgc4YhTUeIUjDheZRweGixc4Doc5J6dGG2aX;u Moq0NlQyOjR6OUi=
H1975 M17kdWtqdmG|ZTDBd5NigQ>? NYLidGw4OC5|MzFOwG0> MomwNkBp M1r0ZWROW09? MUPkc4V{KG6xdDDpcohq[mm2IFXHSnIhVDh3OGKvWFc6OE1iZH;1ZoxmKG23dHHueEBie3Onc4Pl[EBieyC{ZXT1Z5Rqd25iaX6gRWtVKHCqb4PwbI9zgWyjdHnvci=> M1j0d|I1OTJ2OEm4
H1975 M2DGO2tqdmG|ZTDBd5NigQ>? MlLPNE4{OyEQvF2= M1Xn[VIhcA>? NYPvbYc3TE2VTx?= NWDySHpD\G:nczDuc5QhcW6qaXLpeEBGT0[UIFy4OVhTN1R5OUDNJIRwfWKuZTDteZRidnRiYYPz[ZN{\WRiYYOgdoVlfWO2aX;uJIlvKEWUSzDwbI9{eGixconsZZRqd25? NFjQVYgzPDF{NEi5PC=>
H1975 MoDKT4lv[XOnIFHzd4F6 NEn6N3ExNjN|IN88US=> NVrGenpROiCq NFvmc5RFVVOR MkLS[I9meyCwb4SgbY5pcWKrdDDFS2ZTKEx6NUjSM3Q4QTCPIHTveYJt\SCvdYThcpQheGixc4Doc5J6dGG2aX;u MVOyOFEzPDh7OB?=
H1975 Mki3T4lv[XOnIFHzd4F6 MVmwMlEzPSEQvF2= MmjhNlQhcA>? NUm3XpJKTE2VTx?= NU[yd2Nw\G:nczDuc5QhcW6qaXLpeEBGT0[UIFy4OVhTN1R5OUDNJI12fGGwdDDZNVA3QCCjdYTvdIhwe3Cqb4L5cIF1cW:w MVeyNlM{QTN2Mh?=
H1975 MYTLbY5ie2ViQYPzZZk> MoD6NE42KM7:TR?= Mk\BNlQhcA>? NHnnO49FVVOR NH;uUZpld2W|IH7veEBqdmirYnn0JGVITlJiTEi1PHIwXDd7MF2gcZV1[W62LX3l[IlifGWmIFXyb{BxcG:|cHjvdplt[XSrb36= NYL1SXRKOjJ|M{mzOFI>
H1975 NFPqOGVMcW6jc3WgRZN{[Xl? NUjLT2VKOC53IN88US=> NHjHVWMzPCCq M2XqTGROW09? NIXlZZFld2W|IH7veEBqdmirYnn0JGVITlJiTEi1PHIwXDd7MF2gcZV1[W62LX3l[IlifGWmIFHreEBxcG:|cHjvdplt[XSrb36= MUGyNlM{QTN2Mh?=
MIAPaCa2 MomzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NX;VWYE6Oi53IN88US=> MmjZO|IhcA>? M{T0b2ROW09? NUPXbYxscGG|IH7vJIdzd3e2aDDpcohq[mm2aX;u M2\aeFIxPDZ4NUW1
MIAPaCa2 NFHrdJJEgXSxdH;4bYMhSXO|YYm= NGX5RWIyKM7:TR?= M3fkWFExKGR? NILUdnFFVVOR M{TGO4hieyCwbzDjfZRwfG:6aXPpeJkh[XO|ZYPz[YQh[XNic4XwdJJme3Orb36gc4Yh[2:ub375JIZwem2jdHnvci=> NX3LNVVvOjB2Nk[1OVU>
MIAPaCa2 NGHM[4VCeG:ydH;zbZMhSXO|YYm= M3r2elExKM7:TR?= M3O2S|I1cCCxcjC0PEBp NGD5bllFVVOR NHXUd5Rld2W|IH7veEBqdmS3Y3WgZZBweHSxc3nz Ml\oNlA1PjZ3NUW=
MIAPaCa2 M1SwU2Fxd3C2b4Ppd{BCe3OjeR?= MX6yNEDPxE1? NXL1PXlSOjRiaB?= NWT5NVE{TE2VTx?= NXWwe3dN\G:nczDuc5QhcW6mdXPlJIFxd3C2b4Ppd{Bie3Onc4Pl[EBieyClYYPwZZNmKDNiYXP0bZZifGmxbh?= M3f5ZlIxPDZ4NUW1
EoL-1 MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnHuTWM2OD13LkG3JI5O M33Oe3NCVkeHUh?=
NCI-H720 M4LlUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXLnWmZpUUN3ME2yOk46OiCwTR?= NFvZPWtUSU6JRWK=
NCI-SNU-5 MnrHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkXJTWM2OD1{OD6xPUBvVQ>? MlrnV2FPT0WU
EW-3 MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVnrVWV6UUN3ME20Ok4xPCCwTR?= NVXNSlNCW0GQR1XS
HCC2218 MnfZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmTsTWM2OD13MD61PUBvVQ>? NF\YOVZUSU6JRWK=
HuO-3N1 M2nQU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUTkdlFFUUN3ME21Ok4xQSCwTR?= NH7SRmdUSU6JRWK=
DB M4TkbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NInDOFFKSzVyPU[wMlk3KG6P NIfTTmdUSU6JRWK=
HSC-4 NWnrVXFQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUHJR|UxRTZzLkWzJI5O MYTTRW5ITVJ?
DOK MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoHkTWM2OD17Mz62NkBvVQ>? NXH0NJBXW0GQR1XS
H9 M3\YTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYD5NmF1UUN3ME2xN|cvOiCwTR?= NH60O|dUSU6JRWK=
NCI-H292 M3fQO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVf5Z2J3UUN3ME2xOlIvPjZibl2= MlL1V2FPT0WU
HSC-2 MkW1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MX3JR|UxRTF4NT61O{BvVQ>? M1rofHNCVkeHUh?=
LU-65 NHfS[GJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2LYVmlEPTB;MU[2MlYyKG6P NV\mclRLW0GQR1XS
BV-173 MmTnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVHJR|UxRTF6Nj61OUBvVQ>? MXLTRW5ITVJ?
LB2241-RCC NEDtNHFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVPKepZpUUN3ME2xPVQvQTNibl2= MmfVV2FPT0WU
KG-1 NYLq[mlNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUHJR|UxRTJyND6zOEBvVQ>? NYrRe3pWW0GQR1XS
CHL-1 NEXrR|ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4Du[mlEPTB;MkC4MlUyKG6P M{XGbnNCVkeHUh?=
KYSE-140 MojSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUnJR|UxRTJyOT65OkBvVQ>? MXPTRW5ITVJ?
DU-145 M4\qfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M335NGlEPTB;MkG5MlA1KG6P M3jVbXNCVkeHUh?=
EW-13 M4fCOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlmyTWM2OD1{MkWuNUBvVQ>? NIHtN|JUSU6JRWK=
KYSE-450 NELpT2tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NF73b2JKSzVyPUK0O{46OiCwTR?= MV;TRW5ITVJ?
CAL-72 M37nO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWLwZVVnUUN3ME2yOlgvPzNibl2= M2LvPHNCVkeHUh?=
MEG-01 NYfB[Xk6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGXvN2NKSzVyPUK3Ok44PiCwTR?= MorXV2FPT0WU
HCE-T NFXKT|VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWTsWIRMUUN3ME2yO|kvPzlibl2= NH23RWRUSU6JRWK=
NCI-SNU-1 NInEU41Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEmwe2hKSzVyPUK4N{4{OiCwTR?= Mlu5V2FPT0WU
CAL-27 M3n0[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mo\3TWM2OD1{OEmuNFghdk1? MmTwV2FPT0WU
BALL-1 NF;3c|hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVX6O4JHUUN3ME2yPVcvPDJibl2= M2nKUnNCVkeHUh?=
SBC-1 MnHZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXzBTpRuUUN3ME2zNFcvPzlibl2= NFLF[WdUSU6JRWK=
CAL-54 MlHiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1PjdWlEPTB;M{GxMlI{KG6P NGPaUG5USU6JRWK=
TI-73 MlTBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXTJR|UxRTNzMj63OUBvVQ>? MmLjV2FPT0WU
P12-ICHIKAWA NHvXT|lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXvJR|UxRTN{OD6wOkBvVQ>? M1jD[nNCVkeHUh?=
ACHN MlzkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVLJR|UxRTN|MT60JI5O MlPUV2FPT0WU
PC-14 Ml\NS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NH7ScYlKSzVyPUOzN{41OSCwTR?= MljoV2FPT0WU
HCC1806 MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUTJR|UxRTN|Nz61NUBvVQ>? Mk\UV2FPT0WU
SK-MEL-24 M1r0dWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXTJR|UxRTN|Nz64O{BvVQ>? Mny3V2FPT0WU
A4-Fuk NGTTNGdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mkn4TWM2OD1|NUCuNFIhdk1? MXvTRW5ITVJ?
ECC10 NUn2SINCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3\Xe2lEPTB;M{WyMlk3KG6P MoXiV2FPT0WU
KASUMI-1 M1fZdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1fjNWlEPTB;M{[2Mlc{KG6P NU\k[|hbW0GQR1XS
CAL-33 NEXGdJlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mo\qTWM2OD1|N{CuPUBvVQ>? MYTTRW5ITVJ?
MDA-MB-175-VII NX;FXollT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHO5VnlKSzVyPUO3PE45QCCwTR?= M{G4[nNCVkeHUh?=
NUGC-3 NF\we2lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXTJR|UxRTRyMT64NUBvVQ>? NFLQdlNUSU6JRWK=
KY821 NIjNc4xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUPI[YszUUN3ME20NFgvPTdibl2= M{nnenNCVkeHUh?=
CTB-1 NX73WJM5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3\RbWlEPTB;NEK0MlQhdk1? M1HuRnNCVkeHUh?=
DoTc2-4510 NXfVPIR{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEPDOGVKSzVyPUS0Nk4yOiCwTR?= NXzoe|ROW0GQR1XS
EFO-27 MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXrJR|UxRTR3ND63OEBvVQ>? NX3GSWFFW0GQR1XS
BPH-1 M{PCbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXvJR|UxRTR7MT6xOkBvVQ>? NYniUZJkW0GQR1XS
KYSE-270 Ml3mS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MX3JR|UxRTR7OD62OUBvVQ>? M2j5R3NCVkeHUh?=
HO-1-N-1 M1:1R2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MY\JR|UxRTVyOT6yOUBvVQ>? NFnKb3NUSU6JRWK=
SK-MEL-1 M3XTfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYjJR|UxRTVzMD65PUBvVQ>? MmK1V2FPT0WU
MOLT-13 NWXxWXZ1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NV7QR2dWUUN3ME21NVQvQDJibl2= M2C0bHNCVkeHUh?=
TK10 NG\F[FRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHX3OG5KSzVyPUWxOU4yOSCwTR?= NGTTU3BUSU6JRWK=
HN NVjLRolvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkezTWM2OD13MUeuN|ghdk1? Mmj5V2FPT0WU
SCC-15 M1q2NWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFyySodKSzVyPUWyOU43QCCwTR?= MW\TRW5ITVJ?
NCI-H358 Mk\iS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmGwTWM2OD13MkeuOlYhdk1? NV3lV2RRW0GQR1XS
KYSE-180 MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Ml\3TWM2OD13M{CuOlIhdk1? NFzLZplUSU6JRWK=
NCI-H82 M3vzSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{nRcWlEPTB;NUSwMlUhdk1? M37Qb3NCVkeHUh?=
NB7 MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIT5O5dKSzVyPUW0Ok4{OiCwTR?= NG[wb5NUSU6JRWK=
DSH1 NIXMbpdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NF\yc45KSzVyPUW2Ok45QCCwTR?= NUfxU|hLW0GQR1XS
RS4-11 NY\kXJBET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXr4S5NUUUN3ME21OlgvPTlibl2= M1;1VnNCVkeHUh?=
CAN MoOwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHvSW3ZKSzVyPUW4NE44PiCwTR?= NHW1b4FUSU6JRWK=
Ca9-22 MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFzTPINKSzVyPUW4PE43PCCwTR?= NEjDOIhUSU6JRWK=
CAL-39 MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M33odWlEPTB;NUm2MlMhdk1? MUDTRW5ITVJ?
NCI-H1623 MlLQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NX;MbnIzUUN3ME21PVkvOzZibl2= NF;sRo5USU6JRWK=
FADU MmXvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWfJR|UxRTZyND62PUBvVQ>? Ml7YV2FPT0WU
NB69 NHm1UZlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHTv[ZJKSzVyPU[xOE4{PSCwTR?= M3HEdnNCVkeHUh?=
Ramos-2G6-4C10 NH\sfHBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MX3JR|UxRTZ{MT60OkBvVQ>? NWXxOlFMW0GQR1XS
LB1047-RCC NGDUNHBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVXJR|UxRTZ{NT6yPUBvVQ>? NH\2SGtUSU6JRWK=
MV-4-11 M2P1[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFjFdoJKSzVyPU[yO{44KG6P NVK2SmJoW0GQR1XS
DBTRG-05MG M3LETmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWrJR|UxRTZ|Mj6yPEBvVQ>? M3i2cXNCVkeHUh?=
ME-180 NHXsfpVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUTJR|UxRTZ|Mj65JI5O M{HQPHNCVkeHUh?=
NBsusSR NV7lN5N1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NV7Ee3Q1UUN3ME22OFYvPTJibl2= M1rsOHNCVkeHUh?=
COR-L105 MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYDJR|UxRTZ4Mj61N{BvVQ>? NFnyfHZUSU6JRWK=
ETK-1 NFzod2xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWPJR|UxRTZ4Mj61PUBvVQ>? NX7pdo1uW0GQR1XS
L-363 MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnHHTWM2OD14N{GuPVQhdk1? MYnTRW5ITVJ?
LU-134-A Mn;3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUm1ZXVqUUN3ME23NVkvODlibl2= MlTQV2FPT0WU
NCI-H1770 NWrDbohJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHLnNmpKSzVyPUeyNk41KG6P MmPtV2FPT0WU
HAL-01 NXzYZ5hYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFjmTW1KSzVyPUezOE44OSCwTR?= NF3wUlVUSU6JRWK=
COLO-684 MkfyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWHJR|UxRTd3Mz6wNUBvVQ>? MUnTRW5ITVJ?
TE-6 Mn;6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NET3VnFKSzVyPUe2OE4{OSCwTR?= MYTTRW5ITVJ?
A431 NHK2NJlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1HwTmlEPTB;N{iwMlA1KG6P NVvBRYZqW0GQR1XS
LU-135 MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFPIN|ZKSzVyPUe4N{4xOyCwTR?= NXTlcGdtW0GQR1XS
EC-GI-10 NXPve|JNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3mwPWlEPTB;N{i4MlUzKG6P MX;TRW5ITVJ?
TE-12 MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NF\KbnFKSzVyPUiyNU4yOSCwTR?= M3nwPHNCVkeHUh?=
LoVo M{PHb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEXSNWNKSzVyPUi1PU4xPiCwTR?= M2fHOnNCVkeHUh?=
23132-87 Mo[zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEL2fItKSzVyPUi2OE4zQCCwTR?= M1jUbHNCVkeHUh?=
AU565 NWfHPGRsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHvGSnlKSzVyPUi2PU43KG6P MnfuV2FPT0WU
DEL MnyxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NW\leFBLUUN3ME24O|cvPjVibl2= NXriRVN7W0GQR1XS
COR-L88 MkHjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWjJR|UxRTh6Mj6yOkBvVQ>? M{G5SnNCVkeHUh?=
NCI-H2126 NVTvUpNpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoLvTWM2OD16OEKuPFMhdk1? NYnVWFZYW0GQR1XS
CAPAN-1 MnTXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3\3[GlEPTB;OEizMlI6KG6P MWjTRW5ITVJ?
BT-474 NVfvbmR3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlnQTWM2OD17M{iuNVQhdk1? MlzoV2FPT0WU
BHY MoDLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUfMRmVmUUN3ME25O|UvPDhibl2= NGjT[5RUSU6JRWK=
HT-3 NEfDZ21Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHu3PZJKSzVyPUm4Nk41OSCwTR?= NV7wNXFGW0GQR1XS
SK-NEP-1 MlLCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmG3TWM2OD17OEmuOFQhdk1? MnvTV2FPT0WU
MS-1 MlLZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIPGSFNKSzVyPUm5OE43QSCwTR?= NXnOOGpjW0GQR1XS
DOHH-2 M1rEe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnzlTWM2OD1zLkCwNFIyKM7:TR?= Mmm5V2FPT0WU
NCI-H1304 MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Ml7tTWM2OD1zLkCxOlQ{KM7:TR?= M164fnNCVkeHUh?=
EM-2 NGPjNGpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1zGc2lEPTB;MT6wN|AyPiEQvF2= NXXab5VEW0GQR1XS
MHH-PREB-1 M2jMZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkTaTWM2OD1zLkC4OFUyKM7:TR?= M4jvR3NCVkeHUh?=
KU-19-19 NEC4[ZhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXSxbFY4UUN3ME2xMlA5PTRzIN88US=> NGDKc|NUSU6JRWK=
NCI-H1648 Ml6wS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXm5XId2UUN3ME2xMlExPjF4IN88US=> NXqxUpA1W0GQR1XS
MKN1 MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWXJR|UxRTFwMkG5PFch|ryP M1rvVnNCVkeHUh?=
SNU-449 MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIfiPWRKSzVyPUGuNlIzODhizszN MoS1V2FPT0WU
OAW-42 NVTObVBRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYTnV4NOUUN3ME2xMlI4QDJ3IN88US=> NInOXXVUSU6JRWK=
769-P M3nIe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXLJR|UxRTFwMke5NVgh|ryP MnfhV2FPT0WU
SW1088 MoO5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUnVPYYxUUN3ME2xMlI6PjB5IN88US=> M33HUnNCVkeHUh?=
GCIY NH7TVpJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFrmfWhKSzVyPUGuN|AyOzJizszN MUjTRW5ITVJ?
CTV-1 M3nh[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVLJR|UxRTFwM{C4JO69VQ>? NXm0WIIxW0GQR1XS
NCI-H1092 NEDPW2xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXTyS2hCUUN3ME2xMlMxQDVizszN MmfQV2FPT0WU
NKM-1 Ml;kS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWnJR|UxRTFwM{K1PVch|ryP NIq2flVUSU6JRWK=
NCI-H1650 NX;DVZhtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFTSXmRKSzVyPUGuN|M1QDJizszN MmTvV2FPT0WU
SW954 MmfuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mk\UTWM2OD1zLkO0NFQ5KM7:TR?= MlnaV2FPT0WU
SW48 NYH3NG9mT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoDFTWM2OD1zLkO2OlE5KM7:TR?= M2DQUnNCVkeHUh?=
SK-N-DZ NVXVeW9tT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3P1Z2lEPTB;MT6zOlk1PyEQvF2= MY\TRW5ITVJ?
KMOE-2 MlHrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MljRTWM2OD1zLkO5PFE2KM7:TR?= MniyV2FPT0WU
NB5 MmrzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MX;JR|UxRTFwNEC4PVQh|ryP NUf4bm5yW0GQR1XS
CCRF-CEM MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYnJR|UxRTFwNEGxNUDPxE1? NXvLeFR4W0GQR1XS
RH-1 MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVfJR|UxRTFwNEGxN|Yh|ryP NGj4T5BUSU6JRWK=
NCI-H526 MmXCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUez[2RkUUN3ME2xMlQ{QDJ4IN88US=> NGD1NI9USU6JRWK=
697 M4\3b2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFvSS4RKSzVyPUGuOFQyODRizszN MVfTRW5ITVJ?
J82 M1m5XGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnTyTWM2OD1zLkS1O|Y3KM7:TR?= MlTSV2FPT0WU
BE-13 M13CU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NInuPIxKSzVyPUGuOVA3PzFizszN NEXCRmVUSU6JRWK=
SAS MoezS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoTGTWM2OD1zLkWxOlIzKM7:TR?= MnXRV2FPT0WU
SCC-25 NYfyS3FUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1jqcGlEPTB;MT61NlMzOiEQvF2= M2rSO3NCVkeHUh?=
LAMA-84 Mn;zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHfqR4JKSzVyPUGuOVM5OTVizszN NVPyOZRrW0GQR1XS
HSC-3 MoDXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEX4RXRKSzVyPUGuOVQ{QCEQvF2= Mnj3V2FPT0WU
BT-549 NWrpblV[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmfLTWM2OD1zLkW4O|Q4KM7:TR?= NWe5S2lyW0GQR1XS
ML-2 NVjhXYIyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4LPcmlEPTB;MT62OFAzQSEQvF2= MkHuV2FPT0WU
BB30-HNC M2j4T2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3;GemlEPTB;MT62PFk4OiEQvF2= NHzY[FNUSU6JRWK=
PANC-03-27 MnnES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mlm3TWM2OD1zLkewNVM6KM7:TR?= Mn\JV2FPT0WU
COLO-678 MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEHHXGFKSzVyPUGuO|M1PDRizszN Mn;wV2FPT0WU
NCI-H1666 NWK5cmpET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4\KOGlEPTB;MT63OFcxPCEQvF2= MojkV2FPT0WU
NCI-H209 M3joVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUjJR|UxRTFwN{eyOlkh|ryP MnfyV2FPT0WU
EPLC-272H M4T4OWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmTRTWM2OD1zLki1OVQ6KM7:TR?= MVjTRW5ITVJ?
OMC-1 NIrES5ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MV3JR|UxRTFwOUm4PFgh|ryP MUfTRW5ITVJ?
HCC70 MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnyxTWM2OD1{LkCwPFE2KM7:TR?= NIfTPWhUSU6JRWK=
CAL-12T MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXjIVlFpUUN3ME2yMlAyQDZzIN88US=> M3jZOHNCVkeHUh?=
TGBC24TKB MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYnJR|UxRTJwMEK5OlEh|ryP NWrhXnpKW0GQR1XS
EKVX NV;yd49iT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHq4ZlJKSzVyPUKuNFQ6OzlizszN MXvTRW5ITVJ?
SW1116 M{i5VWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYDJR|UxRTJwME[wNFkh|ryP M2Lj[XNCVkeHUh?=
NCI-H2009 NILNWXBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFrXU4tKSzVyPUKuNFYzOTRizszN MoH1V2FPT0WU
RPMI-8866 NFzpbJBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGnOUJJKSzVyPUKuNFg1QDFizszN NVfQdW5kW0GQR1XS
KARPAS-45 M3vBZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Ml3iTWM2OD1{LkGyOFc6KM7:TR?= NYX0ZVJCW0GQR1XS
RXF393 NI[1UW9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NG\M[W9KSzVyPUKuNVMxOzZizszN NIP2RYtUSU6JRWK=
786-0 M{i2Vmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUfJR|UxRTJwMUi0NFYh|ryP MV3TRW5ITVJ?
SCC-4 NULsV497T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MV;JR|UxRTJwMkG3O|Yh|ryP NXToWZRtW0GQR1XS
BT-20 MnXzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4LZemlEPTB;Mj6yOlc1PCEQvF2= MnXmV2FPT0WU
A498 MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFr1ZpRKSzVyPUKuNlk1OTVizszN MlPlV2FPT0WU
IGROV-1 MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NV\s[5d2UUN3ME2yMlMyOjN5IN88US=> NFe0NXRUSU6JRWK=
JVM-3 NH[xNY1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3y1WWlEPTB;Mj6zOFY1OyEQvF2= Ml;ZV2FPT0WU
NCI-H2170 M2P0bGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUDLepM1UUN3ME2yMlM1Pzh|IN88US=> NFnXSmhUSU6JRWK=
EW-18 NUDBUXJqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWHweVNYUUN3ME2yMlM2PDdzIN88US=> NUjCe5ZEW0GQR1XS
KU812 M4\tNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MonOTWM2OD1{LkO2O|c6KM7:TR?= MkXyV2FPT0WU
NY NFLKUG9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3HFO2lEPTB;Mj6zO|I4KM7:TR?= Moi2V2FPT0WU
HTC-C3 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NELoZ4dKSzVyPUKuOFIzPjdizszN Mn3VV2FPT0WU
CFPAC-1 MkTKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXHNOZQ3UUN3ME2yMlQ{QDZ2IN88US=> MVvTRW5ITVJ?
HH NETGO5RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmXoTWM2OD1{LkS5PFU1KM7:TR?= NFj5WVFUSU6JRWK=
MKN7 NEHwVZVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2XjRWlEPTB;Mj62Nlc1QCEQvF2= MorLV2FPT0WU
TE-8 MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGjYfJFKSzVyPUKuOlM3PTNizszN MofPV2FPT0WU
MC-IXC MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MV\JR|UxRTJwNkS0OVMh|ryP M1fCc3NCVkeHUh?=
DMS-79 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHfIOopKSzVyPUKuOlkzQDRizszN MoPWV2FPT0WU
Detroit562 MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2PsRmlEPTB;Mj62PVg1PSEQvF2= MVPTRW5ITVJ?
HuP-T4 MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{TXS2lEPTB;Mj63NlgyQCEQvF2= M4XyXHNCVkeHUh?=
QIMR-WIL NUXV[4FsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXjJR|UxRTJwN{W5OVIh|ryP Mmm3V2FPT0WU
BB65-RCC Mln2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUTJR|UxRTJwOEC3NVMh|ryP NFKycFNUSU6JRWK=
PC-3 MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEjvcGVKSzVyPUKuPFM{OTdizszN NXjLOo1kW0GQR1XS
OVCAR-3 MkDnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWHtfmlrUUN3ME2yMlg2PTl2IN88US=> M3jNWXNCVkeHUh?=
KYSE-510 NGjHSWxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1;uWWlEPTB;Mj64Olc5PiEQvF2= NFXHU|dUSU6JRWK=
HC-1 M3flVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M37WOWlEPTB;Mj65OFAyOiEQvF2= M2LqOnNCVkeHUh?=
NCI-H1693 NXvhfWZ[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXrYPWI4UUN3ME2yMlk2QDl5IN88US=> M13tTHNCVkeHUh?=
DU-4475 MlT1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYT2VZNrUUN3ME2yMlk6ODV{IN88US=> NIfHTXlUSU6JRWK=
COLO-680N M3:yNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoOzTWM2OD1|LkCwOFk2KM7:TR?= Ml3uV2FPT0WU
MN-60 MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NH3VO|hKSzVyPUOuNFQ6PzRizszN MXHTRW5ITVJ?
BCPAP NYDnU45RT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWfCSHJvUUN3ME2zMlA5Ojl3IN88US=> NWO5VoFWW0GQR1XS
647-V NGDSOYVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MW\JR|UxRTNwMU[yNkDPxE1? NX3uNohEW0GQR1XS
HT-1376 NVPyO5BYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEe1bpBKSzVyPUOuNlA2ODZizszN NXzVPXZDW0GQR1XS
NCI-H1793 MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NETMTI1KSzVyPUOuNlExQThizszN NWf0U5lHW0GQR1XS
SW1463 NHXmTmRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYnJR|UxRTNwMk[xPVIh|ryP NWPz[Ig1W0GQR1XS
NCI-H727 MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIfh[VZKSzVyPUOuN|g2QDRizszN MVjTRW5ITVJ?
LB771-HNC NHP5e45Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{P6TWlEPTB;Mz6zPVEzPiEQvF2= NX7tTVA2W0GQR1XS
D-542MG NIXENJhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFLobG5KSzVyPUOuOFQzOjJizszN Ml;6V2FPT0WU
NTERA-S-cl-D1 NHSwZY5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXj4S3dmUUN3ME2zMlQ1QTV5IN88US=> Mk\hV2FPT0WU
C8166 NF;YSpZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NX;ZWVV[UUN3ME2zMlQ3PTJzIN88US=> NWTwR4FYW0GQR1XS
639-V NWTKPVZIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NED6WI5KSzVyPUOuOVc4QTJizszN M17tS3NCVkeHUh?=
TE-1 NXfkeot3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGHHSJhKSzVyPUOuOVkyPjlizszN M2HtW3NCVkeHUh?=
OAW-28 M3L1Z2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFzqZlRKSzVyPUOuOVk1OjZizszN NVHtcGx5W0GQR1XS
SK-LU-1 M1rTcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlXITWM2OD1|Lk[wOlQ2KM7:TR?= Mn;ZV2FPT0WU
CaR-1 Mlm5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUfJR|UxRTNwNkGwOFgh|ryP NXfqTXQzW0GQR1XS
A2780 M3jpdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlfiTWM2OD1|Lk[0NFg6KM7:TR?= NWrm[lkxW0GQR1XS
C2BBe1 NGXYSlFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWXxNmZvUUN3ME2zMlY1PDB5IN88US=> MmPNV2FPT0WU
SK-MES-1 NFnWOm5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3;0bmlEPTB;Mz62OFYyPCEQvF2= NX;nZWhiW0GQR1XS
PANC-10-05 M37mNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYTJR|UxRTNwN{KwO|Ih|ryP MXrTRW5ITVJ?
J-RT3-T3-5 MlLlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVLJR|UxRTNwN{W0NFYh|ryP MXPTRW5ITVJ?
ES4 NGrneIJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlK3TWM2OD1|LkiyNlg3KM7:TR?= NWTRT453W0GQR1XS
NCI-H28 MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MX3JR|UxRTNwOEK5OlEh|ryP NGDiVmdUSU6JRWK=
NCI-H1155 NXzBb3lTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnPQTWM2OD1|Lki0NVU6KM7:TR?= MlTHV2FPT0WU
KURAMOCHI M{P4eWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MY\JR|UxRTNwOE[wOVYh|ryP MYjTRW5ITVJ?
NCI-H69 NWH5UFNPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUTJR|UxRTNwOUCxO|gh|ryP NGTUb4tUSU6JRWK=
IST-MES1 NHyxU4VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnTMTWM2OD1|Lkm0NFI6KM7:TR?= M2fESnNCVkeHUh?=
NH-12 NXz1W3B5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mnv5TWM2OD1|Lkm0NVg4KM7:TR?= M37meXNCVkeHUh?=
JVM-2 NY\UO3lkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MljqTWM2OD1|Lkm0O|UzKM7:TR?= Mki1V2FPT0WU
EW-16 NVfBSJFWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUfH[HZDUUN3ME2zMlk2PTd5IN88US=> NF;5R4tUSU6JRWK=
NCI-H441 NU\k[IVTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmHJTWM2OD1|Lkm3NFE1KM7:TR?= MXzTRW5ITVJ?
RCC10RGB MkPWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{TsdmlEPTB;ND6wNVI1PiEQvF2= MWLTRW5ITVJ?
TCCSUP Mmf2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGHnXY9KSzVyPUSuNVExPSEQvF2= M4nCWXNCVkeHUh?=
HL-60 M2rC[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXvUcGF2UUN3ME20MlEzOjRzIN88US=> M{PmV3NCVkeHUh?=
EW-11 NXvWfolXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{TLVGlEPTB;ND6xN|I3OSEQvF2= MkXKV2FPT0WU
KARPAS-299 NUX5UnJIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mn7PTWM2OD12LkOxNFE{KM7:TR?= M3fXe3NCVkeHUh?=
SNU-C2B M161cGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2X2N2lEPTB;ND6zOFY5PiEQvF2= NVfyRYpSW0GQR1XS
LU-139 NHP2TY1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MV\JR|UxRTRwM{eyOFch|ryP MV;TRW5ITVJ?
HCC1937 Ml30S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmTSTWM2OD12LkO3PVk{KM7:TR?= MVXTRW5ITVJ?
GR-ST NIf4VmZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MoXjTWM2OD12LkSzNVgh|ryP M3;McnNCVkeHUh?=
SK-OV-3 NFS2ZWxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4W1UWlEPTB;ND60OlA1OiEQvF2= Mk\lV2FPT0WU
A172 NEjTdXNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVvJR|UxRTRwNUW1NlEh|ryP MVvTRW5ITVJ?
NB10 MoPYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGnSZlVKSzVyPUSuOVk4QDFizszN MV3TRW5ITVJ?
P30-OHK M2j3bWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkDRTWM2OD12LkixPVI6KM7:TR?= MkW5V2FPT0WU
KYSE-520 M3fCOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{PlNGlEPTB;ND64PFAyQCEQvF2= NXXBSWVrW0GQR1XS
KNS-62 NIXo[|lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MluyTWM2OD12LkmwPFA4KM7:TR?= NF7ydGZUSU6JRWK=
ES1 NXrHb4NoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3zjNGlEPTB;ND65OlA{PSEQvF2= NGK3R4pUSU6JRWK=
KOSC-2 M1\Hc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFGwV3BKSzVyPUSuPVk6PTlizszN NXqxfFAxW0GQR1XS
TE-9 NUntfmhNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnfBTWM2OD13LkCxOVI2KM7:TR?= M{LBSnNCVkeHUh?=
NCI-H1838 NILabHpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEPNVlBKSzVyPUWuNFIxPzZizszN MXHTRW5ITVJ?
KP-N-YN NXu3S|ZYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHuxVJFKSzVyPUWuNVI2QTFizszN NETjXVFUSU6JRWK=
ALL-PO MnfMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWnTbo56UUN3ME21MlIzPTh5IN88US=> NEC3b|NUSU6JRWK=
NOMO-1 NIr6cYtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWLJR|UxRTVwMkOxO|Yh|ryP MVrTRW5ITVJ?
CGTH-W-1 NUfKSpRRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVLJR|UxRTVwM{i1PFQh|ryP MULTRW5ITVJ?
ATN-1 MkC1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUPJR|UxRTVwNEGxPFQh|ryP MUTTRW5ITVJ?
AGS NFvYS4xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHrMZpFKSzVyPUWuOFk3OThizszN M1vnU3NCVkeHUh?=
SW13 MmO1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1r3U2lEPTB;NT61N|I3PSEQvF2= MWLTRW5ITVJ?
SW1990 M2nJZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUPJR|UxRTVwNkKyPFUh|ryP NWr0S3RCW0GQR1XS
BFTC-905 M4\ud2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NESyN2NKSzVyPUWuOlU5PzhizszN MnT1V2FPT0WU
RMG-I MnH1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MX;JR|UxRTVwNkW5OFIh|ryP NWX2VYRZW0GQR1XS
HD-MY-Z M2HUZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFXpeXNKSzVyPUWuOlg2QDFizszN NIPhW2NUSU6JRWK=
HCC1187 NGPwXoJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlfITWM2OD13LkexNFMzKM7:TR?= M3Hl[HNCVkeHUh?=
HCC2998 M1vzOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWrJ[WhrUUN3ME21MlcyQDd5IN88US=> M3PDSXNCVkeHUh?=
RT-112 M4S0fmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYfJR|UxRTVwOUCyOFUh|ryP NInDNVdUSU6JRWK=
CAKI-1 NWTIWJd[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MljuTWM2OD14LkCwPVg2KM7:TR?= NWS5XXk3W0GQR1XS
HDLM-2 MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NX3hNWZXUUN3ME22MlAyPDh7IN88US=> NEfjPHlUSU6JRWK=
TE-10 NFvURVNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NITrSoVKSzVyPU[uNFQ5OzNizszN MX\TRW5ITVJ?
KE-37 NEDrWFVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mk[4TWM2OD14LkC3NlU5KM7:TR?= MWLTRW5ITVJ?
RCM-1 Mnm4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUTJR|UxRTZwMEe3NVkh|ryP M1\SWnNCVkeHUh?=
Mewo NH24ZXpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M33Wb2lEPTB;Nj6xNVQ5PyEQvF2= MmrNV2FPT0WU
L-428 NH21R41Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYTQZVR{UUN3ME22MlE5ODN5IN88US=> MWLTRW5ITVJ?
8-MG-BA MnzJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NH;XRYdKSzVyPU[uNVk{PzlizszN MmPpV2FPT0WU
SK-MEL-28 NH;FbFJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVvJR|UxRTZwMkC5Olch|ryP NX:5dox[W0GQR1XS
VA-ES-BJ Ml3sS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NV3ndVNNUUN3ME22MlMxPDZ{IN88US=> NHLPWZFUSU6JRWK=
CAL-120 NVq3ZYhoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGfnPWRKSzVyPU[uOFUyPjJizszN MXTTRW5ITVJ?
GAMG NUG0VJp[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1OzUWlEPTB;Nj61NFYzKM7:TR?= M3TkcXNCVkeHUh?=
MSTO-221H MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVvYNYhWUUN3ME22MlUyOTdizszN M1f2eHNCVkeHUh?=
GCT MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYXJR|UxRTZwNUOzPFch|ryP MojOV2FPT0WU
SH-4 NGjycIlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MoXiTWM2OD14LkW4PFQ1KM7:TR?= NWL4U|N2W0GQR1XS
Calu-3 M3K0TGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIPCWWxKSzVyPU[uOlU2PjhizszN MWrTRW5ITVJ?
SK-HEP-1 M4H0NGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVrPSFJlUUN3ME22MlcyPzV|IN88US=> M2L6U3NCVkeHUh?=
PFSK-1 NUL0WVVJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXrQRWFsUUN3ME22Mlc{PDd6IN88US=> MVnTRW5ITVJ?
NB12 MmLES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnThTWM2OD14Lke4OFA1KM7:TR?= MmTPV2FPT0WU
A388 M4f2W2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFTIbWJKSzVyPU[uPFk2OiEQvF2= MY\TRW5ITVJ?
KLE MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4fGO2lEPTB;Nj65OlUyPiEQvF2= NUS0OGpMW0GQR1XS
TE-11 MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{\4e2lEPTB;Nz6wOFk3PyEQvF2= NX;PPG1PW0GQR1XS
NCI-H2405 Mn\IS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NF\ZcIpKSzVyPUeuNFg{QTNizszN NUHtXHlNW0GQR1XS
OVCAR-4 MofsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NG\JVmxKSzVyPUeuNVU{PSEQvF2= NGnucVFUSU6JRWK=
KP-N-YS NGi1d41Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3zWUGlEPTB;Nz6xPFE1KM7:TR?= MXvTRW5ITVJ?
NOS-1 MoDxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Moq3TWM2OD15LkK1PFI5KM7:TR?= MljSV2FPT0WU
DMS-114 M3K1Vmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2Lw[GlEPTB;Nz6yPVY{OSEQvF2= M4qyTHNCVkeHUh?=
NCI-H2030 MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXrJR|UxRTdwM{O2PVgh|ryP NUXMSlhrW0GQR1XS
HEL MoHzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnLjTWM2OD15LkO3OVIyKM7:TR?= MkG3V2FPT0WU
CAL-62 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{XSNGlEPTB;Nz6zPVg3PiEQvF2= MknBV2FPT0WU
COLO-668 M{HVTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUnJR|UxRTdwNEO5Olch|ryP M4rtd3NCVkeHUh?=
SKG-IIIa NHHpN21Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWDJR|UxRTdwNEWzPFEh|ryP MULTRW5ITVJ?
HCC1419 MoLkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1vVZWlEPTB;Nz60Olg{OyEQvF2= M1PGT3NCVkeHUh?=
OS-RC-2 NVjDZ2dIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXvJR|UxRTdwNEm4PVQh|ryP Mn;YV2FPT0WU
COLO-829 NV\RXVRzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHnjSINKSzVyPUeuOlY1PjNizszN NHfuNnpUSU6JRWK=
NB13 MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUnJR|UxRTdwOEK2Olch|ryP NGXGTZlUSU6JRWK=
DK-MG MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmLITWM2OD15LkizNlAyKM7:TR?= MlniV2FPT0WU
SHP-77 NFjzR|dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Ml7tTWM2OD15Lki2OlU{KM7:TR?= MnfMV2FPT0WU
NCI-H661 M4fp[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4nxWGlEPTB;OD6wOVg3PyEQvF2= NGrw[2NUSU6JRWK=
AM-38 M4j5[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVjJR|UxRThwMU[yPEDPxE1? NV7BN3BwW0GQR1XS
VM-CUB-1 MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NE\o[YlKSzVyPUiuNVcxOjlizszN MoK0V2FPT0WU
KYSE-70 M2nqTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoXTTWM2OD16LkG5O|YyKM7:TR?= MkS4V2FPT0WU
5637 NEnMcYlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFHJTW1KSzVyPUiuN|ExPTVizszN NEXtXWlUSU6JRWK=
TGBC11TKB NXTHNZg5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2TH[mlEPTB;OD60OlE3PCEQvF2= Mlu5V2FPT0WU
EGI-1 NX2weFFrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{DobWlEPTB;OD62NFA5QCEQvF2= NX[0XlhbW0GQR1XS
D-392MG NVLVbVFxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYfJR|UxRThwNk[yNVQh|ryP MYTTRW5ITVJ?
A673 MkHnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYLJR|UxRThwNke2NVEh|ryP MYTTRW5ITVJ?
COLO-792 MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWnJR|UxRThwN{S5OFYh|ryP NEPRRVNUSU6JRWK=
NCI-H1792 MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1m4e2lEPTB;OD64PFkxOyEQvF2= M3HpZ3NCVkeHUh?=
LS-1034 NGLT[FJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MX;JR|UxRThwOUS2OVIh|ryP NEXFfGhUSU6JRWK=
D-566MG MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NH\xNHZKSzVyPUmuNFE5OSEQvF2= MlzmV2FPT0WU
NCI-H226 MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlWyTWM2OD17LkC5JO69VQ>? MmfzV2FPT0WU
ChaGo-K-1 MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUfuZ2xNUUN3ME25MlExPTd7IN88US=> M1jLcXNCVkeHUh?=
NCI-H2228 MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWXJR|UxRTlwMUGwPFEh|ryP M1Xic3NCVkeHUh?=
RPMI-8226 MlruS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M37uVmlEPTB;OT6xNVMxPCEQvF2= MkThV2FPT0WU
BFTC-909 NXGw[VFMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXfJR|UxRTlwMUiyPVch|ryP MVHTRW5ITVJ?
HPAF-II NVPDfYNwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVLNdVB6UUN3ME25MlIzPTF6IN88US=> NELlVIZUSU6JRWK=
Capan-2 NWnpNpJZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkLsTWM2OD17LkSwNVA6KM7:TR?= MnvyV2FPT0WU
IA-LM MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4WwfGlEPTB;OT60NVk3PiEQvF2= NXX6XVk3W0GQR1XS
KP-4 NVjaToxuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXPJR|UxRTlwNEi4N|gh|ryP NIjHe2hUSU6JRWK=
A101D Mmi0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHji[5NKSzVyPUmuOVE4OTlizszN MoPqV2FPT0WU
EFO-21 M1S2Rmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYrJR|UxRTlwNUi3N|Uh|ryP MXzTRW5ITVJ?
C32 NIG1bYZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NX;3U|d7UUN3ME25MlY{OzRizszN M13LdHNCVkeHUh?=
SW837 MlPUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NY\wVVRiUUN3ME25Mlg1QDJizszN M2ToW3NCVkeHUh?=
OCI-AML2 NV7sc|BKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVHYOnU5UUN3ME25Mlg3QTZizszN MUXTRW5ITVJ?
NCI-H1355 MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2PG[2lEPTB;OT65OFA5QCEQvF2= NUC1flV1W0GQR1XS
NCI-H2342 NHTwNmRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHHJbI1KSzVyPUGwMlAyPTVizszN MWfTRW5ITVJ?
A204 NYrBZVVkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkDiTWM2OD1zMD6wOFY3KM7:TR?= MVnTRW5ITVJ?
CAL-51 MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHv2WJBKSzVyPUGwMlA5PzdizszN M2rSV3NCVkeHUh?=
HCE-4 NW\PXGY{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWHJR|UxRTFyLkGxNlIh|ryP NE\QSVhUSU6JRWK=
NCI-H810 M2S4dWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVHJR|UxRTFyLkG1PVch|ryP M2XtTXNCVkeHUh?=
DJM-1 M1fnPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGHObXZKSzVyPUGwMlE4OzJizszN MlPGV2FPT0WU
SK-UT-1 M{LFS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoK3TWM2OD1zMD6yOVc1KM7:TR?= NUH4e2dJW0GQR1XS
U031 MlrRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUfmXIlzUUN3ME2xNE4zPjh4IN88US=> M33wRXNCVkeHUh?=
YH-13 MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2nXOWlEPTB;MUCuN|A2PyEQvF2= MnH3V2FPT0WU
K5 NY\yXXRNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlvoTWM2OD1zMD6zN|k2KM7:TR?= M3zKSnNCVkeHUh?=
HEC-1 Mnn4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYnMNHBzUUN3ME2xNE41ODhzIN88US=> MnS5V2FPT0WU
A2058 NXXjOYdCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFHJbWZKSzVyPUGwMlU1QTFizszN MYLTRW5ITVJ?
SW962 MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVLHPG46UUN3ME2xNE43OjB2IN88US=> NGHjU|hUSU6JRWK=
VMRC-RCZ MlHZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEfPRVJKSzVyPUGwMlY4PDlizszN NUT2NXRsW0GQR1XS
D-336MG NVLl[ZB[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmfjTWM2OD1zMD63NFA2KM7:TR?= MYLTRW5ITVJ?
LXF-289 MlXVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnzBTWM2OD1zMD63PVY4KM7:TR?= NGi4flZUSU6JRWK=
SW900 NGS0WW5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFvhR3dKSzVyPUGwMlgzOjhizszN NIOwco9USU6JRWK=
K-562 MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWDGfnlvUUN3ME2xNE45Ozl3IN88US=> M4HEVHNCVkeHUh?=
HCC38 M{jLR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEW3PIZKSzVyPUGwMlk4OTZizszN MV;TRW5ITVJ?
SF-295 M4mxT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYH5coN3UUN3ME2xNE46QTB{IN88US=> NFK3[4tUSU6JRWK=
LB831-BLC NI\1cWpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVLJR|UxRTFzLkK1OVYh|ryP M{L4c3NCVkeHUh?=
FTC-133 MlrxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFu3O4NKSzVyPUGxMlMxQDFizszN Mn7CV2FPT0WU
HCC1954 MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmLLTWM2OD1zMT60N|Yh|ryP MnL3V2FPT0WU
GOTO MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYPJR|UxRTFzLkWyNFYh|ryP NG\ocodUSU6JRWK=
LS-411N M2W4Umdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHHrcYZKSzVyPUGxMlYyODFizszN Mm\JV2FPT0WU
RPMI-7951 MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVi5TGEzUUN3ME2xNU43OzR6IN88US=> M3PJeXNCVkeHUh?=
NCI-H1299 MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3T6WWlEPTB;MUGuOlY1PyEQvF2= M{SzVHNCVkeHUh?=
MLMA MnHRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIXNdo9KSzVyPUGxMlY6QTdizszN Mnr1V2FPT0WU
MMAC-SF M3r2fWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYHJR|UxRTFzLkeyOVIh|ryP NG\EdZZUSU6JRWK=
UM-UC-3 MlTNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHn5c4xKSzVyPUGxMlc1OjFizszN MX\TRW5ITVJ?
SCC-9 MnnnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlnXTWM2OD1zMT64NVUyKM7:TR?= MXrTRW5ITVJ?
HOS M4WyNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFLjXm5KSzVyPUGxMlg3QDNizszN M3XTPXNCVkeHUh?=
OE19 NIrsclRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVnJR|UxRTFzLkmzOlch|ryP NEDKbJZUSU6JRWK=
Mo-T Mn7kS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmX1TWM2OD1zMT65OVQyKM7:TR?= NHn2ZotUSU6JRWK=
CAMA-1 MkfwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHuwbXFKSzVyPUGyMlE3OzNizszN NYf1bo41W0GQR1XS
U-118-MG MmrRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M33rVGlEPTB;MUKuNlQ1OSEQvF2= NWj3XWVVW0GQR1XS
KS-1 NGrvbXdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlHtTWM2OD1zMj6yPFMzKM7:TR?= NFfZOGpUSU6JRWK=
JAR M4nOWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1HSfGlEPTB;MUKuN|M3QSEQvF2= NEDVeWlUSU6JRWK=
ABC-1 NXzQc2h{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlHMTWM2OD1zMj6zOFEh|ryP MYDTRW5ITVJ?
Daoy NI\qeZhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MU\JR|UxRTF{LkS1OFIh|ryP M{HpRnNCVkeHUh?=
C3A MlXJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVrJR|UxRTF{LkW3PFUh|ryP M3\OW3NCVkeHUh?=
GT3TKB M2nYS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4XTPGlEPTB;MUKuOlMzPyEQvF2= NUfNNlNFW0GQR1XS
DMS-273 M33idmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mlr6TWM2OD1zMj64OlM{KM7:TR?= MUTTRW5ITVJ?
G-361 NHrFUplIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlPMTWM2OD1zMj65NVI6KM7:TR?= MkDEV2FPT0WU
RH-18 NIjnWXhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWjPVXhLUUN3ME2xN{4zQTZ{IN88US=> MVzTRW5ITVJ?
SN12C NHjpNVlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUK4doZGUUN3ME2xN{4{QDB6IN88US=> Mn3jV2FPT0WU
NCI-H1993 Ml;yS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXTJR|UxRTF|LkSyPFUh|ryP NFH2W3lUSU6JRWK=
LOXIMVI M3H0Tmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkjUTWM2OD1zMz62NVUyKM7:TR?= MVjTRW5ITVJ?
SK-PN-DW M33Ee2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUXJR|UxRTF|Lki0Nlch|ryP Mm\PV2FPT0WU
KALS-1 M4TGcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmflTWM2OD1zMz64OVI2KM7:TR?= MVXTRW5ITVJ?
LAN-6 M1HtXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHy3T2lKSzVyPUG0MlI2OyEQvF2= MW\TRW5ITVJ?
A549 NH34N2ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1;ETGlEPTB;MUSuOFcyOiEQvF2= MXnTRW5ITVJ?
RD MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3\0[mlEPTB;MUSuOFgyOyEQvF2= MWHTRW5ITVJ?
TGBC1TKB NFSzd21Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWjN[pAzUUN3ME2xOE43PjF3IN88US=> M2LsXnNCVkeHUh?=
NCI-H630 M2nBeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFHudlZKSzVyPUG0Mlk1PjdizszN M1rLSXNCVkeHUh?=
MIA-PaCa-2 MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVyzUW1sUUN3ME2xOE46PjlizszN MXzTRW5ITVJ?
NCI-H1755 NGToVJFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXTjb3M2UUN3ME2xOE46QTV|IN88US=> NWXDVolJW0GQR1XS
MOLT-4 NGXlSoRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUTJR|UxRTF3LkC0PVch|ryP NY\4T5dWW0GQR1XS
CW-2 M1LMNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXy4UZN[UUN3ME2xOU4yPDJzIN88US=> MVzTRW5ITVJ?
COLO-320-HSR M4XncGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIrsWmRKSzVyPUG1MlU{ODdizszN MXvTRW5ITVJ?
UMC-11 M3y2UWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MX7JR|UxRTF3Lke1NlMh|ryP Mn\uV2FPT0WU
MCF7 MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFnibVJKSzVyPUG1MlgyPDVizszN MWPTRW5ITVJ?
NCI-H23 MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4S5PWlEPTB;MUWuPFQ{QCEQvF2= M4XHW3NCVkeHUh?=
HuCCT1 MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWDJR|UxRTF3Lki3OEDPxE1? MWDTRW5ITVJ?
MPP-89 MmXQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFPkNnVKSzVyPUG1Mlk1OTdizszN MkLVV2FPT0WU
HT55 MnPtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYTJR|UxRTF3Lkm0O|gh|ryP MYfTRW5ITVJ?
no-11 NWW5WpliT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWfJR|UxRTF3Lkm2OlMh|ryP NFvZRXFUSU6JRWK=
GP5d MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFPpZZBKSzVyPUG2MlIyQDdizszN MWHTRW5ITVJ?
BHT-101 M2HBTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYr4dFc3UUN3ME2xOk4zPDN7IN88US=> MlfnV2FPT0WU
M059J MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1XRZ2lEPTB;MU[uNlg1KM7:TR?= MmDaV2FPT0WU
D-283MED NITRSWxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1PhSGlEPTB;MU[uOFIxQSEQvF2= MmrWV2FPT0WU
BEN NF;tdHVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUnsOZA6UUN3ME2xOk42OTV3IN88US=> MnrnV2FPT0WU
LB373-MEL-D NXHJRZpRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mn73TWM2OD1zNj63NlMzKM7:TR?= MknSV2FPT0WU
MEL-HO MoXSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYP2Z3IzUUN3ME2xOk45QDV2IN88US=> NGjGSFFUSU6JRWK=
GI-ME-N MkHjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NV7DdoR6UUN3ME2xOk46ODN{IN88US=> MXLTRW5ITVJ?
RKO NFnnTYVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1nURWlEPTB;MUeuNFc1QCEQvF2= MUDTRW5ITVJ?
MZ2-MEL NHTIVHNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWLG[4EzUUN3ME2xO{4yOzNizszN NIDEbVhUSU6JRWK=
NCI-H1573 NI\teJpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NI\VO2VKSzVyPUG3MlI5OjZizszN MWjTRW5ITVJ?
NCI-H1581 M3f0bGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYX3UGZqUUN3ME2xO{41PDFzIN88US=> NXTacmNDW0GQR1XS
NCI-H747 MoK2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NETCVXBKSzVyPUG3MlUzQTdizszN NYf5T49sW0GQR1XS
SW1783 MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYPsVlFZUUN3ME2xO{43PDF3IN88US=> MXLTRW5ITVJ?
Calu-6 NUTwNos6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M17RNWlEPTB;MUeuOlc5OiEQvF2= Ml7uV2FPT0WU
SF268 M2ezXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIG2NWJKSzVyPUG3MlY6PjlizszN NHvzb5VUSU6JRWK=
ES8 MkL2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlXtTWM2OD1zNz64OVk{KM7:TR?= MnGzV2FPT0WU
KM-H2 NXz5WotJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnjoTWM2OD1zNz65OFEyKM7:TR?= M3vXdXNCVkeHUh?=
D-502MG M1jYV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWrJR|UxRTF5Lkm4NFgh|ryP NIHWfZlUSU6JRWK=
HLE NHzEO2lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIjqSXpKSzVyPUG4MlMyPDhizszN NITxSpNUSU6JRWK=
SW982 NFTEZYNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXT2UZpMUUN3ME2xPE41ODd3IN88US=> MX;TRW5ITVJ?
MDA-MB-361 MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2TwSmlEPTB;MUiuOVU5QCEQvF2= NXXDdZk{W0GQR1XS
NCI-H1563 NIfWTZNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mnu1TWM2OD1zOD63NVI1KM7:TR?= NFPaOWRUSU6JRWK=
MFE-280 NHracJpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYDqS4IyUUN3ME2xPE44Ojl|IN88US=> NWjxTXpXW0GQR1XS
U251 MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIr0XlhKSzVyPUG4Mlc{PDdizszN MlPZV2FPT0WU
KNS-42 MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoLETWM2OD1zOD64NFE2KM7:TR?= MWrTRW5ITVJ?
U-266 NE\QfmxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4m4R2lEPTB;MUiuPFY1QSEQvF2= Mk\NV2FPT0WU
OVCAR-8 MmXXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWrJR|UxRTF6LkmyO|Yh|ryP MWTTRW5ITVJ?
MFH-ino MkTqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2HZO2lEPTB;MUiuPVY3QSEQvF2= MVXTRW5ITVJ?
D-263MG NIjPZ|RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYTJR|UxRTF7LkCxO|Ih|ryP MnjiV2FPT0WU
NCI-H1437 NWL5RpFnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEHkd2JKSzVyPUG5MlA1PjdizszN NF7PU3lUSU6JRWK=
NCI-H1048 NEH0SVBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHvodGxKSzVyPUG5MlI{OjZizszN NXLsXYdoW0GQR1XS
NCI-H446 NIfQ[ZhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4PVbWlEPTB;MUmuN|U5QSEQvF2= M3SzcnNCVkeHUh?=
NCI-N87 Ml76S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4H3[2lEPTB;MUmuOVk6OiEQvF2= NFrMV2ZUSU6JRWK=
WM-115 MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3LEbGlEPTB;MUmuOlc4PCEQvF2= MXnTRW5ITVJ?
HuH-7 Mn;hS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlzhTWM2OD1zOT63OFIyKM7:TR?= MXvTRW5ITVJ?
NCI-H650 NIDEU2ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmDOTWM2OD1zOT63OVA5KM7:TR?= M{f5ZnNCVkeHUh?=
TYK-nu NHnuOYFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEPqWZBKSzVyPUG5Mlg{PzhizszN MnPVV2FPT0WU
Becker M{LTbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NE\2XnhKSzVyPUG5Mlg2PDdizszN NXn2R2dKW0GQR1XS
BB49-HNC M4PCZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mm\VTWM2OD1zOT65NkDPxE1? MV;TRW5ITVJ?
HGC-27 NWLiOmhuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1m3U2lEPTB;MkCuNVM6PCEQvF2= MnzEV2FPT0WU
SiHa M{\QR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MojhTWM2OD1{MD6zO|EzKM7:TR?= NF7NXWhUSU6JRWK=
LB2518-MEL MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXrJR|UxRTJyLkO3N|kh|ryP NI\4e41USU6JRWK=
TE-5 NH\kOmJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUXJR|UxRTJyLke0PFIh|ryP MXPTRW5ITVJ?
IST-SL1 NX:xPINET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoP3TWM2OD1{MD63PFc6KM7:TR?= MmTmV2FPT0WU
A375 NHXHfG1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmH1TWM2OD1{MT6wOVY4KM7:TR?= NVixcWFjW0GQR1XS
MC116 M{joO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NULhN|hiUUN3ME2yNU4xPzJ|IN88US=> NXroOYh5W0GQR1XS
GI-1 NU\qNYVmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVHQUHBXUUN3ME2yNU4yPyEQvF2= NGm0eXBUSU6JRWK=
HOP-62 Ml;uS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkTOTWM2OD1{MT6yO|g1KM7:TR?= NEjqNoFUSU6JRWK=
PA-1 MnPHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXTEfVFrUUN3ME2yNU4zPzh5IN88US=> MmHXV2FPT0WU
HT M1XBTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEDYSGZKSzVyPUKxMlQ{OzFizszN MnPOV2FPT0WU
HUTU-80 M3e5Z2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXrJR|UxRTJzLkSzN|Yh|ryP MkjuV2FPT0WU
NCI-H1975 MljyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIS3TFhKSzVyPUKxMlQ3OSEQvF2= NILOd2xUSU6JRWK=
GAK NYfpPJN6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MX7JR|UxRTJzLkS5PUDPxE1? NFjRUIFUSU6JRWK=
SK-N-AS M3;qUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1XrbWlEPTB;MkGuOVYyQSEQvF2= MY\TRW5ITVJ?
OE33 NI[5eGtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MW\JR|UxRTJzLk[wOFYh|ryP MlKwV2FPT0WU
YKG-1 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoLBTWM2OD1{MT62OVQ2KM7:TR?= Ml36V2FPT0WU
CAL-85 M3rNXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3qyNGlEPTB;MkGuPVMxPSEQvF2= NXK4Ull{W0GQR1XS
NCI-H2347 MkfNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFy4NlNKSzVyPUKxMlk1OjhizszN MXjTRW5ITVJ?
PANC-08-13 NVLmUlJJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2j3VmlEPTB;MkKuNFEyQSEQvF2= NYnNRXNFW0GQR1XS
SK-N-FI M4OwU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlX5TWM2OD1{Mj6zNFc1KM7:TR?= NUf5UG1KW0GQR1XS
NEC8 MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWPJR|UxRTJ{LkWwO|gh|ryP NYXP[YZVW0GQR1XS
AN3-CA M1;hb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYnrTYdPUUN3ME2yNk43ODh2IN88US=> MoTkV2FPT0WU
HuO9 NWKyR3BwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXPyWYllUUN3ME2yNk44Ozl4IN88US=> Moe2V2FPT0WU
COLO-800 NGTNWZdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MX3JR|UxRTJ{Lke2OVMh|ryP NFnzNGFUSU6JRWK=
HT-29 NXnjXnFbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWfJR|UxRTJ{Lki4NlMh|ryP M2m5fXNCVkeHUh?=
OC-314 M2rhemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NI\2R45KSzVyPUKyMlg5PDVizszN M3fCdnNCVkeHUh?=
G-401 M3LwUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mn7DTWM2OD1{Mz6wOFYzKM7:TR?= MnLDV2FPT0WU
Saos-2 NE[1SoVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVTJR|UxRTJ|LkWxPFIh|ryP NE\kS25USU6JRWK=
UACC-62 M1T4[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NInlW2JKSzVyPUKzMlU5OzNizszN M3PhcXNCVkeHUh?=
D-247MG MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYjJR|UxRTJ|Lke5N|kh|ryP NF\QUmRUSU6JRWK=
COLO-741 NHnIOY1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M121TmlEPTB;MkOuPVU3PSEQvF2= NFHWVFFUSU6JRWK=
ES3 MnfQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFnm[|hKSzVyPUK0MlAxOjNizszN MkX3V2FPT0WU
LNCaP-Clone-FGC M3vZcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MV7JR|UxRTJ2LkCyNVEh|ryP NHfIOGZUSU6JRWK=
SW1710 MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NH\STZVKSzVyPUK0MlE2ODZizszN NX;xR|N6W0GQR1XS
LU-99A Ml[wS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXTJR|UxRTJ2LkG4OFEh|ryP NIrTNG9USU6JRWK=
HOP-92 M3TUb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWTI[5FNUUN3ME2yOE44OjVizszN MmnxV2FPT0WU
LS-123 NYi3WXgzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVXWRYFsUUN3ME2yOE46PjF2IN88US=> Mmm4V2FPT0WU
T84 MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2niUmlEPTB;MkSuPVc3PSEQvF2= MYfTRW5ITVJ?
HCT-116 MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXjrZVNUUUN3ME2yOU41OTh4IN88US=> M1ntUnNCVkeHUh?=
M14 NW\xeVNRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MULJR|UxRTJ3LkS0OFch|ryP M2foNHNCVkeHUh?=
OCUB-M MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVLJR|UxRTJ3LkS0OVYh|ryP NIL0VZNUSU6JRWK=
MKN45 M2noXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4rSZWlEPTB;MkWuOlMyPSEQvF2= M3nD[nNCVkeHUh?=
LCLC-97TM1 M4HP[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXfJR|UxRTJ3LkeyPFUh|ryP MWLTRW5ITVJ?
RVH-421 Mn\OS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGHJVHlKSzVyPUK1MlgyPjFizszN MUfTRW5ITVJ?
NKS-81-FD MlnwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2P5SGlEPTB;MkWuPVAzOSEQvF2= MXnTRW5ITVJ?
NCI-H596 M{LjTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHrWXnlKSzVyPUK2MlA1QDdizszN MlPhV2FPT0WU
GB-1 MmfDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYrPc|ZDUUN3ME2yOk4yQDd7IN88US=> M{HVbHNCVkeHUh?=
ZR-75-30 Mon2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{WwTmlEPTB;Mk[uNlI6PyEQvF2= MVfTRW5ITVJ?
U-2-OS M1:wS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NULhfFV6UUN3ME2yOk4{PzV5IN88US=> MmDhV2FPT0WU
HuP-T3 NWHTdZpET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4XSRWlEPTB;Mk[uOlExOiEQvF2= MVPTRW5ITVJ?
MOLT-16 MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXvJR|UxRTJ4Lk[xOlYh|ryP NV;aTHJZW0GQR1XS
U-87-MG MmC5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1z5dmlEPTB;Mk[uO|Q{QCEQvF2= MYnTRW5ITVJ?
8505C M37S[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NV74U3hGUUN3ME2yOk46OTJ4IN88US=> NHu2dVlUSU6JRWK=
SK-MEL-3 MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVzJR|UxRTJ4Lkm4Nlgh|ryP MkG4V2FPT0WU
COLO-824 MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{XGXWlEPTB;MkeuNlE6PSEQvF2= NHnLd4hUSU6JRWK=
EW-1 MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXXJR|UxRTJ5LkO1OVQh|ryP MYLTRW5ITVJ?
UACC-257 Mn7tS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVu0[JNWUUN3ME2yO{4{QDB2IN88US=> NX3ISJpFW0GQR1XS
Hs-578-T MofhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWPFeFBsUUN3ME2yO{42Ojl7IN88US=> NIi3PIFUSU6JRWK=
UACC-893 NEXJc|BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUHMc|BiUUN3ME2yO{43PjNzIN88US=> M4PhTHNCVkeHUh?=
MHH-NB-11 M2DJWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlKwTWM2OD1{Nz64NFA4KM7:TR?= MlTWV2FPT0WU
KYSE-410 NYPLRXgyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mlm0TWM2OD1{OD6yO|c6KM7:TR?= NGq5dGJUSU6JRWK=
SF126 M2Dw[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2jKUmlEPTB;MkiuO|Q{PSEQvF2= M4DvcHNCVkeHUh?=
HT-144 MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEX6N49KSzVyPUK5MlM{PjJizszN Ml3IV2FPT0WU
SW1573 MojWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1q4RmlEPTB;MkmuN|UxQSEQvF2= MUjTRW5ITVJ?
SW620 NELOU4lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEm2flNKSzVyPUK5MlM3PDFizszN NVTXbW17W0GQR1XS
SCH MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NE\6eZhKSzVyPUK5Mlg5OzFizszN NHTNUXlUSU6JRWK=
EW-22 MnTtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M17uN2lEPTB;M{CuNVk3QSEQvF2= NYjUSHBwW0GQR1XS
H4 M{TsTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnjoTWM2OD1|MD60OlU1KM7:TR?= NXjoZ4trW0GQR1XS
CAS-1 NIHDRnRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmC4TWM2OD1|MD63PFU6KM7:TR?= M1XLUHNCVkeHUh?=
MG-63 M{X4Nmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFL0OGhKSzVyPUOwMlg1PzhizszN M{XLS3NCVkeHUh?=
MDA-MB-415 M3jwT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{PuOWlEPTB;M{GuNVc2OyEQvF2= MXHTRW5ITVJ?
NCI-H1395 MmP1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MX3JR|UxRTNzLkKzNlgh|ryP M3jIRXNCVkeHUh?=
Ca-Ski NYDSOI93T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoX3TWM2OD1|MT6zNVc4KM7:TR?= Mke0V2FPT0WU
BxPC-3 MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVK0cJJHUUN3ME2zNU4{PzJ7IN88US=> NGHacHJUSU6JRWK=
A3-KAW MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoqzTWM2OD1|MT60OFcyKM7:TR?= NGfiRm5USU6JRWK=
T-24 MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVG4NHRbUUN3ME2zNU44OzZ{IN88US=> NULHcYFjW0GQR1XS
NCI-H2029 Mn\NS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHLie2lKSzVyPUOxMlc4PjVizszN MVPTRW5ITVJ?
YAPC MkDSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmjSTWM2OD1|Mj6wOFA4KM7:TR?= NHTlV3NUSU6JRWK=
SK-MEL-2 MnHOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoOxTWM2OD1|Mj6wOVIh|ryP Ml7hV2FPT0WU
LS-513 MlfRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmnPTWM2OD1|Mj6xNVg4KM7:TR?= NG[zbJBUSU6JRWK=
AsPC-1 M{Xjemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYr6bnpOUUN3ME2zNk4{PjB3IN88US=> MXfTRW5ITVJ?
KYSE-150 MkDSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NY\hTJFIUUN3ME2zNk4{Pzd|IN88US=> MYDTRW5ITVJ?
NCI-H520 NYPaeVdUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkjQTWM2OD1|Mj60OFgzKM7:TR?= NUHn[YpyW0GQR1XS
JEG-3 NYf3RZdqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkHYTWM2OD1|Mz6wPVcyKM7:TR?= MkHRV2FPT0WU
GMS-10 NF7TWmtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2e4[WlEPTB;M{OuN|AxPCEQvF2= NX3EdlB[W0GQR1XS
HT-1080 NVrkVHZ7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NETQcIJKSzVyPUOzMlM6KM7:TR?= NVGzVVJVW0GQR1XS
NCI-H1651 NHWxWJZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkTUTWM2OD1|Mz6zPVYh|ryP M1P5dnNCVkeHUh?=
NCI-H2122 NH\BemZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1nRfmlEPTB;M{OuOVU4PCEQvF2= NWPLNlc4W0GQR1XS
ES5 MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3;OR2lEPTB;M{OuO|I6OiEQvF2= M3rzSXNCVkeHUh?=
8305C MoXUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmW3TWM2OD1|Mz65PVM4KM7:TR?= NVqwSpl1W0GQR1XS
KM12 NITqeIZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXO2TFA{UUN3ME2zOE4xPDd6IN88US=> M{S4WnNCVkeHUh?=
HCT-15 NGLEdVFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWXJR|UxRTN2LkGyO{DPxE1? NUPBWJJOW0GQR1XS
OVCAR-5 MkGyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEOwOlBKSzVyPUO0MlIyQDJizszN NX7uW5FxW0GQR1XS
NCI-H2291 NH;EeWRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXjJR|UxRTN2LkK0O|Ih|ryP NYfLUoVkW0GQR1XS
CP50-MEL-B MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWP6RpQ6UUN3ME2zOE43PTl{IN88US=> MUnTRW5ITVJ?
C-33-A NHrrT45Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWHpbZRkUUN3ME2zOE43QDV5IN88US=> NYHxcXloW0GQR1XS
NCI-H2452 NHr0b|ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2DUVWlEPTB;M{SuO|g5OiEQvF2= M2rhSXNCVkeHUh?=
MDA-MB-157 NXLJPY5vT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVfJR|UxRTN2LkixPVMh|ryP Ml6yV2FPT0WU
LN-405 MkjCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlPETWM2OD1|NT60N|A5KM7:TR?= M4TDNXNCVkeHUh?=
MDA-MB-231 M37NNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NH6zRlVKSzVyPUO1MlUxPTRizszN Mn7MV2FPT0WU
EW-24 M2CzT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1P5cmlEPTB;M{WuOlM{PSEQvF2= MWLTRW5ITVJ?
MKN28 MnHmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUH0SHpJUUN3ME2zOU45OjN4IN88US=> M3HxNnNCVkeHUh?=
KINGS-1 MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVPJR|UxRTN3Lki0N|Qh|ryP MUfTRW5ITVJ?
LC-2-ad NFXUb2dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3HsdmlEPTB;M{[uOlk6KM7:TR?= MXnTRW5ITVJ?
IGR-1 MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1rYdGlEPTB;M{[uO|A4PSEQvF2= NHzTdYRUSU6JRWK=
SW626 MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{PlNmlEPTB;M{euNFQyPyEQvF2= MV7TRW5ITVJ?
ONS-76 M3;NTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NG\kUHpKSzVyPUO3MlE{ODlizszN Ml3HV2FPT0WU
T98G NFLNSVNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXfJR|UxRTN5Lki2N|Uh|ryP MlqzV2FPT0WU
NB14 M2\jR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIjCdlVKSzVyPUO4MlQ2PDRizszN Ml;RV2FPT0WU
D-423MG MlrLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NH3MUm5KSzVyPUO4MlQ5PjlizszN NG\XZ2VUSU6JRWK=
NCI-H510A M3zCbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2\TfWlEPTB;M{iuOlQ2OSEQvF2= NVPucGtOW0GQR1XS
NMC-G1 NXLqOJBXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2LwW2lEPTB;M{iuO|IzOiEQvF2= MX\TRW5ITVJ?
SW948 MlvtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVfJR|UxRTN6Lki5OFkh|ryP MV\TRW5ITVJ?
MFM-223 MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4TYNWlEPTB;M{iuPVQ{OSEQvF2= NFH6bFNUSU6JRWK=
PAN1 MorwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHG1c2NKSzVyPUO4Mlk6OTlizszN NFXGNZhUSU6JRWK=
MZ7-mel MkXTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NU\hOG4xUUN3ME2zPU4yOTl7IN88US=> NHXYOZBUSU6JRWK=
COLO-679 MkjuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmXwTWM2OD1|OT65O|A5KM7:TR?= MnfFV2FPT0WU
SW872 MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NF\Mb3VKSzVyPUSwMlIxOzFizszN MX3TRW5ITVJ?
HT-1197 MlnKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWGyUldMUUN3ME20NE4zQDZ7IN88US=> M1m3d3NCVkeHUh?=
ES6 NV6yfZpnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mlf4TWM2OD12MD60OVUzKM7:TR?= Mnr2V2FPT0WU
SNU-387 M3TYeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIHYNFNKSzVyPUSwMlgzOzhizszN MUXTRW5ITVJ?
T47D Mn\nS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmTqTWM2OD12MT6wNVkzKM7:TR?= M3LGNXNCVkeHUh?=
G-402 MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Ml;UTWM2OD12MT6wPFA6KM7:TR?= M1m5VHNCVkeHUh?=
MZ1-PC M3H0fGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFnqcVFKSzVyPUSxMlgyKM7:TR?= MXvTRW5ITVJ?
SW1417 NIGxWYRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVvFTJE1UUN3ME20Nk4{ODNizszN NYPGUXp6W0GQR1XS
RERF-LC-MS NEK1SlZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MU\JR|UxRTR{LkWwPFch|ryP MXXTRW5ITVJ?
SF539 MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIm0fZdKSzVyPUSyMlU2OjlizszN NUHmZZpjW0GQR1XS
ESS-1 NVPxSIkzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{\aNWlEPTB;NEOuOVU2QCEQvF2= Mm[0V2FPT0WU
RO82-W-1 MoO2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MorhTWM2OD12Mz62NVU{KM7:TR?= MkH0V2FPT0WU
S-117 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVjIdWw2UUN3ME20N{43QTV6IN88US=> MX7TRW5ITVJ?
SW756 MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1OydmlEPTB;NEOuPFI1OiEQvF2= MVvTRW5ITVJ?
CP66-MEL MnXIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1;4UGlEPTB;NEWuO|E1OyEQvF2= MUXTRW5ITVJ?
H-EMC-SS MoLRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEG2[VZKSzVyPUS1Mlc3QTNizszN NELFV4hUSU6JRWK=
NCI-H2052 NHTTNmlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXvRW4V3UUN3ME20OU46ODJ5IN88US=> MWXTRW5ITVJ?
SW684 Mm\uS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlH6TWM2OD12Nz6wNFgyKM7:TR?= NHL0OVNUSU6JRWK=
HCC1569 NGrUTJhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHnVb|VKSzVyPUS3MlE3PThizszN M4jNUXNCVkeHUh?=
KGN MnzPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NW[xWG52UUN3ME20O{4{OzFzIN88US=> MV3TRW5ITVJ?
LCLC-103H NYHjbFM2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmfuTWM2OD12Nz60OFA1KM7:TR?= MX7TRW5ITVJ?
SW780 M3znRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4DURmlEPTB;NEeuOlM2OSEQvF2= MVHTRW5ITVJ?
NCI-H1703 NGLxOW9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3v2TGlEPTB;NEiuN|M2OiEQvF2= NIOxOY5USU6JRWK=
HCC1395 M2PlW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4CzZWlEPTB;NEiuO|Q{OiEQvF2= MmHvV2FPT0WU

... Click to View More Cell Line Experimental Data

In vivo Gefitinib (100 mg/kg) improves the anti-tumor effect of radiotherapy in LoVo tumor xenografts. [3] Gefitinib treatment of nude mice bearing established human GEO colon cancer xenografts reveals a reversible dose-dependent inhibition of tumor growth because GEO tumors resumes the growth rate of controls at the end of the treatment. [4]

Protocol

Cell Research:[1]
+ Expand
  • Cell lines: NR6, NR6M and NR6W cells
  • Concentrations: 0-2 μM
  • Incubation Time: 72 hours
  • Method: Exponentially growing cells including NR6, NR6M, NR6M and NR6W cells are seeded in sextuple in 96-well plates at a concentration of 2000 cells/well, allowed to adhere and subsequently washed in PBS and incubated overnight in medium containing 0.5% FCS. Cells are then treated with varying concentrations (0-2 μM) of Gefitinib or the solute control DMSO and EGF. The optimal EGF concentration for inducing proliferation of NR6wtEGFR and NR6W cells has previously been determined and hence NR6wtEGFR and NR6W cells are supplemented with 10 nM and 0.1 nM EGF, respectively. EGF is not added to NR6 and NR6M cells. After 72 hours the amount of cells are measured by performing a MTT proliferation assay.
    (Only for Reference)
Animal Research:[3]
+ Expand
  • Animal Models: Female nude mice (cba nu/nu) aged 8–10 weeks are intra-dermal injected with LoVo cells.
  • Formulation: 0.5% polysorbate
  • Dosages: 100 mg/kg
  • Administration: Once daily by oral administration (0.1 mL/10 g body weight) for 14 days
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 89 mg/mL (199.14 mM)
Ethanol 4 mg/mL (8.95 mM)
Water Insoluble
In vivo Add solvents to the product individually and in order(Data is from Selleck tests instead of citations):
1% CMC Na
For best results, use promptly after mixing.
30mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 446.90
Formula

C22H24ClFN4O3

CAS No. 184475-35-2
Storage powder
in solvent
Synonyms N/A

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT03122717 Recruiting Non-Small Cell Lung Cancer Dana-Farber Cancer Institute|AstraZeneca May 9 2017 Phase 1
NCT00025675 Completed Brain and Central Nervous System Tumors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|National Cancer Institute (NCI) October 9 2001 Phase 2
NCT03050164 Completed Bioequivalence Study Hunan Kelun Pharmaceutical Co. Ltd. September 8 2016 Phase 1
NCT01933347 Active not recruiting Non Small Cell Lung Cancer Guangdong Association of Clinical Trials April 7 2014 Phase 2
NCT03486496 Not yet recruiting Lung Adenocarcinoma|EGFR Mutation Fujian Cancer Hospital June 5 2018 Phase 2
NCT01610336 Active not recruiting Non-small Cell Lung Cancer Novartis Pharmaceuticals|Novartis April 5 2012 Phase 2

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Frequently Asked Questions

  • Question 1:

    I try to dissolve Gefitinib (ZD1839) in 0.5% methylcellulose+0.2% Tween 80 for in vivo experiments. However, when I prepare the mixture, it forms precipitates. Exists another way to dissolve completely the compound?

  • Answer:

    S1025 can be dissovled in both 5% DMSO+corn oil and 5% DMSO+30% PEG 300+5% Tween 80+ddH2O at 2.5 mg/ml clearly. It dissolves in DMSO not readily, please sonicate and warm it in water bath at about 45 degree, and dissolve it clearly first. Then add other solvent.

EGFR Signaling Pathway Map

EGFR Inhibitors with Unique Features

Related EGFR Products4

Tags: buy Gefitinib (ZD1839) | Gefitinib (ZD1839) supplier | purchase Gefitinib (ZD1839) | Gefitinib (ZD1839) cost | Gefitinib (ZD1839) manufacturer | order Gefitinib (ZD1839) | Gefitinib (ZD1839) distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID